<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLoS Computational Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-734X</issn>
    <issn pub-type="epub">1553-7358</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8699717</article-id>
    <article-id pub-id-type="pmid">34898596</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1009670</article-id>
    <article-id pub-id-type="publisher-id">PCOMPBIOL-D-20-01216</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Materials Science</subject>
          <subj-group>
            <subject>Materials</subject>
            <subj-group>
              <subject>Insulators</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Chromosome Biology</subject>
            <subj-group>
              <subject>Chromatin</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Epigenetics</subject>
            <subj-group>
              <subject>Chromatin</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Gene Expression</subject>
            <subj-group>
              <subject>Chromatin</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Computational Biology</subject>
          <subj-group>
            <subject>Genome Analysis</subject>
            <subj-group>
              <subject>Genome Annotation</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Genome Analysis</subject>
              <subj-group>
                <subject>Genome Annotation</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Eukaryota</subject>
            <subj-group>
              <subject>Plants</subject>
              <subj-group>
                <subject>Legumes</subject>
                <subj-group>
                  <subject>Peas</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Gene Expression</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Gene Expression</subject>
            <subj-group>
              <subject>Gene Regulation</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Immune Cells</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CoRE-ATAC: A deep learning model for the functional classification of regulatory elements from single cell and bulk ATAC-seq data</article-title>
      <alt-title alt-title-type="running-head">CoRE-ATAC: A deep learning model for the functional classification of regulatory elements</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2421-4225</contrib-id>
        <name>
          <surname>Thibodeau</surname>
          <given-names>Asa</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Khetan</surname>
          <given-names>Shubham</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="currentaff001" ref-type="author-notes">
          <sup>¤</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9473-3317</contrib-id>
        <name>
          <surname>Eroglu</surname>
          <given-names>Alper</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4607-8001</contrib-id>
        <name>
          <surname>Tewhey</surname>
          <given-names>Ryan</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5630-559X</contrib-id>
        <name>
          <surname>Stitzel</surname>
          <given-names>Michael L.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9772-3066</contrib-id>
        <name>
          <surname>Ucar</surname>
          <given-names>Duygu</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, United States of America</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>The Jackson Laboratory, Bar Harbor, Maine, United States of America</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Institute for Systems Genomics, University of Connecticut Health Center, Farmington, Connecticut, United States of America</addr-line>
    </aff>
    <aff id="aff004">
      <label>4</label>
      <addr-line>Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, Connecticut, United States of America</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Roy</surname>
          <given-names>Sushmita</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>University of Wisconsin, Madison, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="current-aff" id="currentaff001">
        <label>¤</label>
        <p>Current address: Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>duygu.ucar@jax.org</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>13</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <volume>17</volume>
    <issue>12</issue>
    <elocation-id>e1009670</elocation-id>
    <history>
      <date date-type="received">
        <day>10</day>
        <month>7</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>19</day>
        <month>11</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 Thibodeau et al</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Thibodeau et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pcbi.1009670.pdf"/>
    <abstract>
      <p><italic toggle="yes">Cis</italic>-Regulatory elements (<italic toggle="yes">cis</italic>-REs) include promoters, enhancers, and insulators that regulate gene expression programs <italic toggle="yes">via</italic> binding of transcription factors. ATAC-seq technology effectively identifies active <italic toggle="yes">cis</italic>-REs in a given cell type (including from single cells) by mapping accessible chromatin at base-pair resolution. However, these maps are not immediately useful for inferring specific functions of <italic toggle="yes">cis</italic>-REs. For this purpose, we developed a deep learning framework (CoRE-ATAC) with novel data encoders that integrate DNA sequence (reference or personal genotypes) with ATAC-seq cut sites and read pileups. CoRE-ATAC was trained on 4 cell types (n = 6 samples/replicates) and accurately predicted known <italic toggle="yes">cis</italic>-RE functions from 7 cell types (n = 40 samples) that were not used in model training (mean average precision = 0.80, mean F1 score = 0.70). CoRE-ATAC enhancer predictions from 19 human islet samples coincided with genetically modulated gain/loss of enhancer activity, which was confirmed by massively parallel reporter assays (MPRAs). Finally, CoRE-ATAC effectively inferred <italic toggle="yes">cis</italic>-RE function from aggregate single nucleus ATAC-seq (snATAC) data from human blood-derived immune cells that overlapped with known functional annotations in sorted immune cells, which established the efficacy of these models to study <italic toggle="yes">cis</italic>-RE functions of rare cells without the need for cell sorting. ATAC-seq maps from primary human cells reveal individual- and cell-specific variation in <italic toggle="yes">cis</italic>-RE activity. CoRE-ATAC increases the functional resolution of these maps, a critical step for studying regulatory disruptions behind diseases.</p>
    </abstract>
    <abstract abstract-type="summary">
      <title>Author summary</title>
      <p>Non-coding DNA sequences serve different functional roles to regulate gene expression. For these sequences to be active, they must be accessible for proteins to bind and carry out specific regulatory functions. Even so, mutations or other regulatory events may modulate their activity or regulatory function, making it critical to infer their function to understand their regulatory impact. Current sequencing technologies capture accessible sequences from low cell numbers, enabling the study of clinical samples. However, determining their functional role remains a challenge. For example, enhancers and insulators serve distinct regulatory functions, yet both fall in open chromatin regions and have similar genomic annotations (i.e., distance to transcription start site). Hence, alternative data sources and features (e.g., from DNA sequence or ATAC-seq data) must be integrated to distinguish them. Towards this goal, we developed CoRE-ATAC to infer whether open chromatin regions correspond to promoters, enhancers, or insulators. We demonstrate that CoRE-ATAC can infer regulatory functions in diverse cell types, capture activity differences modulated by genetic mutations, and can be applied to single cell ATAC-seq data to study rare cell populations. These inferences will further our understanding of how genes are regulated and how these regulatory mechanisms are disrupted with disease.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100001797</institution-id>
            <institution>Pharmaceutical Research and Manufacturers of America Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>Postdoctoral fellowship award in bioinformatics</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2421-4225</contrib-id>
          <name>
            <surname>Thibodeau</surname>
            <given-names>Asa</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id>
            <institution>National Institute of General Medical Sciences</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GM124922</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9772-3066</contrib-id>
          <name>
            <surname>Ucar</surname>
            <given-names>Duygu</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution>Department of Defense (DOD)</institution>
        </funding-source>
        <award-id>W81XWH-18-0401</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5630-559X</contrib-id>
          <name>
            <surname>Stitzel</surname>
            <given-names>Michael L.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This research was supported by the PhRMA Foundation postdoctoral fellowship award in bioinformatics (to AT), and National Institute of General Medical Sciences (NIGMS) under award number GM124922 (to DU), and Department of Defense (DOD) under award number W81XWH-18-0401 (to MLS and DU).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="5"/>
      <table-count count="3"/>
      <page-count count="32"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2021-12-23</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>The analyzed datasets are available from multiple databases (GEO, SRA, ENCODE, and EGA). Accession numbers and websites are listed below. Accession numbers are listed below: GM12878 &amp; CD4T ATAC-seq: (GEO) GSE47753 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47753" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47753</ext-link> K562 ATAC-seq: (GEO) GSE121993 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121993" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121993</ext-link> HSMM ATAC-seq: (GEO) GSE109828 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109828" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109828</ext-link> MCF7 ATAC-seq: (GEO) GSE97583 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97583" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97583</ext-link> Naive CD8 ATAC-seq: (GEO) GSE118189, (EGA) EGAS00001002605 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118189" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118189</ext-link>
<ext-link xlink:href="https://ega-archive.org/studies/EGAS00001002605" ext-link-type="uri">https://ega-archive.org/studies/EGAS00001002605</ext-link> PBMC ATAC-seq: (EGA) EGAS00001002605 <ext-link xlink:href="https://ega-archive.org/studies/EGAS00001002605" ext-link-type="uri">https://ega-archive.org/studies/EGAS00001002605</ext-link> A549 ATAC-seq: (GEO) GSE117089 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117089" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117089</ext-link> EndoC ATAC-seq: (GEO) GSE118588 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588</ext-link> Islet ATAC-seq: (SRA) SRP117935 <ext-link xlink:href="https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP117935" ext-link-type="uri">https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP117935</ext-link> HEPG2 Data: (ENCODE) ENCSR888GEN <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR888GEN/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR888GEN/</ext-link> Heart (Right Atrium): (ENCODE) ENCSR525XSO <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR525XSO/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR525XSO/</ext-link> Heart (Left Ventricle): (ENCODE) ENCSR025UEI <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR025UEI/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR025UEI/</ext-link> Testis: (ENCODE) ENCSR493GDU <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR493GDU/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR493GDU/</ext-link> Body of Pancreas: (ENCODE) ENCSR002JUR <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR002JUR/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR002JUR/</ext-link> Stomach: (ENCODE) ENCSR949WGV <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR949WGV/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR949WGV/</ext-link> Liver (Right Lobe): (ENCODE) ENCSR228KEB <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR228KEB/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR228KEB/</ext-link> Thyroid: (ENCODE) ENCSR646GBV <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR646GBV/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR646GBV/</ext-link> Transverse Colon: (ENCODE) ENCSR654ORD <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR654ORD/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR654ORD/</ext-link> A549 ChIP-seq: (ENCODE) ENCSR797CXN <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR797CXN/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR797CXN/</ext-link> MCF7 ChIP-seq: (ENCODE) ENCSR247DVY <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR247DVY/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR247DVY/</ext-link> Naïve CD8+T ChIP-seq: (ENCODE) ENCSR465PPP <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR465PPP/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR465PPP/</ext-link> CD4+ T ChIP-seq: (GEO) GSE17312, (GEO) GSE12889 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17312" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17312</ext-link>
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12889" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12889</ext-link> Pancreatic Islet ChIP-seq: (GEO) GSE51312, (GEO) GSE23784 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312</ext-link>
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23784" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23784</ext-link> PBMC ChIP-seq: (GEO) GSE16368 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16368" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16368</ext-link> EndoC ChIP-seq: (GEO) GSE118588 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588</ext-link> GM12878 (file prefix=wgEncodeBroadHistoneGm12878), CD14+ (file prefix= wgEncodeBroadHistoneMonocd14ro1746), HSMM (file prefix= wgEncodeBroadHistoneHsmm), K562 (file prefix= wgEncodeBroadHistoneK562) ChIP-seq available via the ENCODE UCSC portal: <ext-link xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/" ext-link-type="uri">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/</ext-link> FANTOM enhancers: <ext-link xlink:href="https://fantom.gsc.riken.jp/5/datafiles/latest/extra/Enhancers/" ext-link-type="uri">https://fantom.gsc.riken.jp/5/datafiles/latest/extra/Enhancers/</ext-link> A549 Starr-seq: (GEO) GSE114063 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114063" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114063</ext-link> snATAC PBMC data: (GEO) GSE129785 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129785" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129785</ext-link> Islet MIN6 MPRA data: (GEO) GSE145643 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145643" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145643</ext-link> CoRE-ATAC code and pretrained models are available on our GitHub page: <ext-link xlink:href="https://github.com/UcarLab/CoRE-ATAC" ext-link-type="uri">https://github.com/UcarLab/CoRE-ATAC</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>The analyzed datasets are available from multiple databases (GEO, SRA, ENCODE, and EGA). Accession numbers and websites are listed below. Accession numbers are listed below: GM12878 &amp; CD4T ATAC-seq: (GEO) GSE47753 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47753" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47753</ext-link> K562 ATAC-seq: (GEO) GSE121993 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121993" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121993</ext-link> HSMM ATAC-seq: (GEO) GSE109828 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109828" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109828</ext-link> MCF7 ATAC-seq: (GEO) GSE97583 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97583" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97583</ext-link> Naive CD8 ATAC-seq: (GEO) GSE118189, (EGA) EGAS00001002605 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118189" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118189</ext-link>
<ext-link xlink:href="https://ega-archive.org/studies/EGAS00001002605" ext-link-type="uri">https://ega-archive.org/studies/EGAS00001002605</ext-link> PBMC ATAC-seq: (EGA) EGAS00001002605 <ext-link xlink:href="https://ega-archive.org/studies/EGAS00001002605" ext-link-type="uri">https://ega-archive.org/studies/EGAS00001002605</ext-link> A549 ATAC-seq: (GEO) GSE117089 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117089" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117089</ext-link> EndoC ATAC-seq: (GEO) GSE118588 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588</ext-link> Islet ATAC-seq: (SRA) SRP117935 <ext-link xlink:href="https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP117935" ext-link-type="uri">https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP117935</ext-link> HEPG2 Data: (ENCODE) ENCSR888GEN <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR888GEN/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR888GEN/</ext-link> Heart (Right Atrium): (ENCODE) ENCSR525XSO <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR525XSO/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR525XSO/</ext-link> Heart (Left Ventricle): (ENCODE) ENCSR025UEI <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR025UEI/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR025UEI/</ext-link> Testis: (ENCODE) ENCSR493GDU <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR493GDU/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR493GDU/</ext-link> Body of Pancreas: (ENCODE) ENCSR002JUR <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR002JUR/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR002JUR/</ext-link> Stomach: (ENCODE) ENCSR949WGV <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR949WGV/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR949WGV/</ext-link> Liver (Right Lobe): (ENCODE) ENCSR228KEB <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR228KEB/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR228KEB/</ext-link> Thyroid: (ENCODE) ENCSR646GBV <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR646GBV/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR646GBV/</ext-link> Transverse Colon: (ENCODE) ENCSR654ORD <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR654ORD/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR654ORD/</ext-link> A549 ChIP-seq: (ENCODE) ENCSR797CXN <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR797CXN/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR797CXN/</ext-link> MCF7 ChIP-seq: (ENCODE) ENCSR247DVY <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR247DVY/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR247DVY/</ext-link> Naïve CD8+T ChIP-seq: (ENCODE) ENCSR465PPP <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR465PPP/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR465PPP/</ext-link> CD4+ T ChIP-seq: (GEO) GSE17312, (GEO) GSE12889 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17312" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17312</ext-link>
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12889" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12889</ext-link> Pancreatic Islet ChIP-seq: (GEO) GSE51312, (GEO) GSE23784 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51312</ext-link>
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23784" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23784</ext-link> PBMC ChIP-seq: (GEO) GSE16368 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16368" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16368</ext-link> EndoC ChIP-seq: (GEO) GSE118588 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118588</ext-link> GM12878 (file prefix=wgEncodeBroadHistoneGm12878), CD14+ (file prefix= wgEncodeBroadHistoneMonocd14ro1746), HSMM (file prefix= wgEncodeBroadHistoneHsmm), K562 (file prefix= wgEncodeBroadHistoneK562) ChIP-seq available via the ENCODE UCSC portal: <ext-link xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/" ext-link-type="uri">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/</ext-link> FANTOM enhancers: <ext-link xlink:href="https://fantom.gsc.riken.jp/5/datafiles/latest/extra/Enhancers/" ext-link-type="uri">https://fantom.gsc.riken.jp/5/datafiles/latest/extra/Enhancers/</ext-link> A549 Starr-seq: (GEO) GSE114063 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114063" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114063</ext-link> snATAC PBMC data: (GEO) GSE129785 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129785" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129785</ext-link> Islet MIN6 MPRA data: (GEO) GSE145643 <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145643" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145643</ext-link> CoRE-ATAC code and pretrained models are available on our GitHub page: <ext-link xlink:href="https://github.com/UcarLab/CoRE-ATAC" ext-link-type="uri">https://github.com/UcarLab/CoRE-ATAC</ext-link>.</p>
  </notes>
</front>
<body>
  <disp-quote>
    <p>This is a <italic toggle="yes">PLOS Computational Biology</italic> Methods paper.</p>
  </disp-quote>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p><italic toggle="yes">Cis</italic>-Regulatory Elements (<italic toggle="yes">cis</italic>-REs) are non-coding DNA sequences that can be bound by transcription factors (TFs) and can take on different functional roles (e.g., promoter, enhancer, or insulator) to regulate gene expression programs. Over 88% of disease associated single nucleotide polymorphisms (SNPs) from genome-wide association studies (GWAS) are within non-coding region of the genome [<xref rid="pcbi.1009670.ref001" ref-type="bibr">1</xref>]. In particular, these SNPs typically fall within cell-specific enhancer sequences and indirectly disrupt gene expression programs [<xref rid="pcbi.1009670.ref002" ref-type="bibr">2</xref>,<xref rid="pcbi.1009670.ref003" ref-type="bibr">3</xref>]. It is therefore critical to map <italic toggle="yes">cis</italic>-REs and their functions with increased precision to study how GWAS SNPs disrupt gene regulation in different cell types. Furthermore, genetic variation can impact the activity level of <italic toggle="yes">cis</italic>-REs [<xref rid="pcbi.1009670.ref004" ref-type="bibr">4</xref>–<xref rid="pcbi.1009670.ref007" ref-type="bibr">7</xref>]. Uncovering the functionality of such genetically-modulated <italic toggle="yes">cis</italic>-REs will help to guide <italic toggle="yes">in-vivo</italic> and <italic toggle="yes">in-vitro</italic> functional studies, by prioritizing genomic loci that are most likely to impact gene regulation for experimental validation. Furthermore, identifying <italic toggle="yes">cis</italic>-RE functions in clinical samples will help uncover individual-specific and disease-associated elements and their functional roles in pathogenesis.</p>
    <p>ENCODE [<xref rid="pcbi.1009670.ref008" ref-type="bibr">8</xref>] and Roadmap [<xref rid="pcbi.1009670.ref009" ref-type="bibr">9</xref>] consortia successfully annotated <italic toggle="yes">cis</italic>-REs for 127 reference human cell/tissue types by profiling their epigenomes and analyzing them using a hidden markov model (HMM) based approach: ChromHMM [<xref rid="pcbi.1009670.ref010" ref-type="bibr">10</xref>]. ChromHMM integrates Chromatin Immunoprecipitation with sequencing (ChIP-seq) profiles of multiple histone modification marks and TFs to demarcate promoters, enhancers, insulators and other <italic toggle="yes">cis</italic>-REfunctions. These reference epigenomes are valuableresources to uncover and study disease-relevant and cell-type-specific <italic toggle="yes">cis</italic>-REs. However, these maps serve as references and do not capture individual- or condition-specific (e.g., activated cells) <italic toggle="yes">cis</italic>-REs. Moreover, these references do not include <italic toggle="yes">cis</italic>-REs of less frequently studied and/or rarer cells that are gaining attention with the advances in single cell profiling techniques. Although ChromHMM is very effective in inferring <italic toggle="yes">cis</italic>-RE function, it requires five or more ChIP-seq assays to be generated from the same sample, which is not always feasible due to the cost (both antibody and sequencing) and cell numbers required for ChIP-seq assays (10<sup>4</sup>−10<sup>6</sup> cells per experiment).</p>
    <p>An alternative strategy for genome-wide interrogation of <italic toggle="yes">cis</italic>-REs is through chromatin accessibility profiling, which identifies open chromatin regions that are accessible for binding of TFs or other regulatory proteins/RNAs. One of the most recent and most frequently used methods for identifying open chromatin regions is Assay for Transposase Accessible Chromatin using Sequencing (ATAC-seq) [<xref rid="pcbi.1009670.ref011" ref-type="bibr">11</xref>,<xref rid="pcbi.1009670.ref012" ref-type="bibr">12</xref>]. ATAC-seq utilizes Tn5 transposase to cleave accessible DNA into fragments, which are sequenced to generate a genome-wide map of open chromatin (<xref rid="pcbi.1009670.g001" ref-type="fig">Fig 1</xref> Top). The low input material needed to generate ATAC-seq libraries allows it to be applied in clinical samples, making it an ideal assay for studying <italic toggle="yes">cis</italic>-REs in individual epigenomes in health and disease. Furthermore, recent developments have enabled the generation of high-quality ATAC-seq maps from single cells (i.e., single nucleus ATAC-seq (snATAC)) [<xref rid="pcbi.1009670.ref013" ref-type="bibr">13</xref>] and generate epigenomic maps from clinical samples of limited quantity. Advances in snATAC-seq technology enables researchers to study chromatin accessibility maps at unprecedented resolution by detecting rarer cell types and by studying epigenomes of cells without the need to sort them, which could affect gene expression programs. Despite these promises of snATAC-seq data, there are not many studies that show that machine learning models built from bulk ATAC-seq data can also be used for predictions on aggregated snATAC-seq data. ATAC-seq is widely used to infer <italic toggle="yes">cis</italic>-REs from diverse cell types and cell states [<xref rid="pcbi.1009670.ref007" ref-type="bibr">7</xref>,<xref rid="pcbi.1009670.ref011" ref-type="bibr">11</xref>,<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>–<xref rid="pcbi.1009670.ref019" ref-type="bibr">19</xref>], however, thefunctionality of these <italic toggle="yes">cis</italic>-REs (e.g., enhancers, promoters, insulators) cannot be inferred from these assays without the help of new computational methods that can fully interrogate ATAC-seq data features and integrate it with DNA sequence features.</p>
    <fig position="float" id="pcbi.1009670.g001">
      <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.g001</object-id>
      <label>Fig 1</label>
      <caption>
        <title>Overview of the CoRE-ATAC framework.</title>
        <p>Paired-end ATAC-seq data captures different cut and insert size distributions corresponding to the presence or absence of nucleosomes or TFs. ATAC-seq data is encoded into a 10x600 matrix and 19 data features from PEAS algorithm to predict the functionality of an open chromatin region, using both novel and manually selected features. In the final step, CoRE-ATAC classifies <italic toggle="yes">cis</italic>-REs into 4 functional classes: promoter, enhancer, insulator, and other.</p>
      </caption>
      <graphic xlink:href="pcbi.1009670.g001" position="float"/>
    </fig>
    <p>Previously, we developed PEAS [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>], a machine learning method that predicts enhancers by first extracting data features (n = 24) and then predicting enhancer activity using a neural network (NN) model. Although PEAS proved to be effective in predicting enhancers from ATAC-seq maps, it primarily utilized manually extracted features; potentially missing novel predictive features that could be hidden within the read count/cut site distributions of ATAC-seq data. Determining which features to extract for better enhancer predictions is a key challenge imposed when using this classical machine learning approach. Furthermore, PEAS was primarily developed to predict enhancer sequences, leaving the open question of whether other types of <italic toggle="yes">cis</italic>-REs can be predicted from ATAC-seq maps.</p>
    <p>Deep learning has revolutionized the machine learning field due to its ability to learn novel data features and has been successfully applied in genomics to predict chromatin accessibility [<xref rid="pcbi.1009670.ref021" ref-type="bibr">21</xref>] and enhancers [<xref rid="pcbi.1009670.ref022" ref-type="bibr">22</xref>,<xref rid="pcbi.1009670.ref023" ref-type="bibr">23</xref>] from DNA sequence. Instead of manually extracting features from the data, deep learning can identify the most predictive features directly. To this end, we developed a deep learning framework, Classification of Regulatory Elements with ATAC-seq (CoRE-ATAC) (<xref rid="pcbi.1009670.g001" ref-type="fig">Fig 1</xref> middle and bottom) which harness the power of deep learning to infer the regulatory function(s) of open chromatin regions and to overcome the limitations of our previous work, PEAS [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>]. Core-ATAC integrates DNA sequence data with chromatin accessibility data (single cell or bulk) using a novel ATAC-seq data encoder that is designed to be able to integrate an individual’s genotype to personalize <italic toggle="yes">cis</italic>-RE predictions, especially for loci with genetically modulated regulatory activity (e.g., eQTLs, caQTLs). In situations where it is not feasible to generate multiple ChIP-seq assays, CoRE-ATAC can effectively infer three active functional states (promoters, enhancers, and insulators) solely from ATAC-seq data. Despite the fact thatCoRE-ATAC does not fully capture all chromatin states that can be inferred <italic toggle="yes">via</italic> ChromHMM annotations, it captures three of the most important/relevant regulatory element types responsible for transcriptional regulation and chromatin architecture.</p>
    <p>In this study, we describe CoRE-ATAC and evaluate its ability to predict <italic toggle="yes">cis</italic>-RE function (i.e., promoters, enhancers, insulators, and others) in 11 different cell types across 46 bulk ATAC-seq samples/replicates (<xref rid="pcbi.1009670.t001" ref-type="table">Table 1</xref>). We demonstrate that CoRE-ATAC is a robust method that consistently predicts <italic toggle="yes">cis</italic>-RE annotations with high average precision (mean micro average precision = 0.8, mean micro average F1 score = 0.7) irrespective of whether the cell type was used in model training. CoRE-ATAC predictions recapitulated ChromHMM enhancers from the cognate cell type as well as <italic toggle="yes">cis</italic>-REs inferred <italic toggle="yes">via</italic> different assays (CAGE [<xref rid="pcbi.1009670.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1009670.ref025" ref-type="bibr">25</xref>] and STARR-seq [<xref rid="pcbi.1009670.ref026" ref-type="bibr">26</xref>]). We compared CoRE-ATAC <italic toggle="yes">cis</italic>-RE predictions in human islet samples to <italic toggle="yes">cis</italic>-RE activity from massively parallel reporter assays (MPRA) [<xref rid="pcbi.1009670.ref027" ref-type="bibr">27</xref>] to demonstrate that CoRE-ATAC can predict the loss/gain of <italic toggle="yes">cis</italic>-RE activity linked to genetic variation. Finally, we showed that models built from bulk ATAC-seq data are also predictive on cell clusters from snATAC-seq data, by predicting <italic toggle="yes">cis</italic>-REs from snATAC-seq data in human Peripheral Blood Mononuclear Cells [<xref rid="pcbi.1009670.ref013" ref-type="bibr">13</xref>] for 7 blood-derived immune cell type clusters. Enhancers inferred from PBMC snATAC-seq data captured the majority of super enhancers in these immune cell subsets [<xref rid="pcbi.1009670.ref002" ref-type="bibr">2</xref>,<xref rid="pcbi.1009670.ref028" ref-type="bibr">28</xref>] (i.e., enhancers that tend to be cell-type-specific) and tend toharbor SNPs for diseases of the cognate cell/tissue type. CoRE-ATAC’s ability to distinguish enhancers from insulators or other open chromatin regions is instrumental for the functional interpretation of open chromatin regions and their remodeling with age and diseases. For example, enhancers play a major role in regulating gene expression programs and tend to harbor disease-causing SNPs [<xref rid="pcbi.1009670.ref002" ref-type="bibr">2</xref>,<xref rid="pcbi.1009670.ref003" ref-type="bibr">3</xref>]. On the other hand, insulators are major players in the three-dimensional (3D) organization of the genome and help establish and maintain this 3D structure [<xref rid="pcbi.1009670.ref029" ref-type="bibr">29</xref>]. An improved functional annotation of open chromatin regions is critical for data interpretation especially while studying epigenetic remodeling in disease-relevant primary human cells and tissues. These analyses demonstrate the potential of CoRE-ATAC to annotate open chromatin regions from both bulk ATAC-seq and cell clusters from snATAC-seq samples, which will ultimately improve our understanding of how gene expression programs are regulated at the individual and cell-specific level and how this regulation is disrupted in pathologies.</p>
    <table-wrap position="float" id="pcbi.1009670.t001">
      <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.t001</object-id>
      <label>Table 1</label>
      <caption>
        <title>ATAC-seq samples used in model training and evaluation.</title>
      </caption>
      <alternatives>
        <graphic xlink:href="pcbi.1009670.t001" id="pcbi.1009670.t001g" position="float"/>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Cell Type</th>
              <th align="left" rowspan="1" colspan="1">Usage</th>
              <th align="left" rowspan="1" colspan="1"># Replicates</th>
              <th align="left" rowspan="1" colspan="1">Data Accession Id</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">CD14<sup>+</sup></td>
              <td align="left" rowspan="1" colspan="1">Model Training</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">EGAS00001002605</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">K562</td>
              <td align="left" rowspan="1" colspan="1">Model Training</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">GSE121993</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HSMM</td>
              <td align="left" rowspan="1" colspan="1">Model Training</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">GSE109828</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">GM12878</td>
              <td align="left" rowspan="1" colspan="1">Model Training</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">GSE47753</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Pancreatic Islets</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">19</td>
              <td align="left" rowspan="1" colspan="1">SRP117935</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Naïve CD8<sup>+</sup> T</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">EGAS00001002605</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PBMC</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">EGAS00001002605</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Naïve CD8<sup>+</sup> T</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">GSE118189</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCF7</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">GSE97583</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">A549</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">GSE117089</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CD4+ T</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">GSE47753</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">EndoC</td>
              <td align="left" rowspan="1" colspan="1">Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">GSE118588</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HEPG2</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR888GEN</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Heart (Right Atrium)</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR525XSO</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Heart (Left Ventricle)</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR025UEI</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Testis</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR493GDU</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Body of Pancreas</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR002JUR</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stomach</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR949WGV</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Liver (Right lobe)</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR228KEB</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Thyroid</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR646GBV</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Transverse Colon</td>
              <td align="left" rowspan="1" colspan="1">Additional Cross-cell Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">ENCSR654ORD</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PBMC</td>
              <td align="left" rowspan="1" colspan="1">snATAC Predictions</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">GSE129785</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
    </table-wrap>
  </sec>
  <sec sec-type="results" id="sec002">
    <title>Results</title>
    <sec id="sec003">
      <title>CoRE-ATAC predicts functional annotations for <italic toggle="yes">cis</italic>-REs</title>
      <p>Annotation of ATAC-seq peaks using ChromHMM states revealed that between 16–52% are promoters, 18–54% are enhancers, 4–15% are insulators (for samples with insulator states in ChromHMM) and 5–55% are other functional annotations (<xref rid="pcbi.1009670.g002" ref-type="fig">Fig 2A</xref>). The functional diversity in these annotations establishes a need for functionally annotating ATAC-seq open chromatin maps. Furthermore ChromHMMstates are effective as baseline references to assess predictive performances of functional annotations [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>] compared to alternatives (e.g., CAGE [<xref rid="pcbi.1009670.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1009670.ref025" ref-type="bibr">25</xref>] or P300 [<xref rid="pcbi.1009670.ref030" ref-type="bibr">30</xref>,<xref rid="pcbi.1009670.ref031" ref-type="bibr">31</xref>] binding) since ChromHMM captures a wider array of functional states and detects a larger set of loci (e.g., enhancers) that can be used in model training. Previously, we showed that ChromHMM captured the majority of both P300 [<xref rid="pcbi.1009670.ref030" ref-type="bibr">30</xref>,<xref rid="pcbi.1009670.ref031" ref-type="bibr">31</xref>] and CAGE [<xref rid="pcbi.1009670.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1009670.ref025" ref-type="bibr">25</xref>] identified enhancers, whereas P300 and CAGE enhancers identified smaller but distinct subsets of enhancers [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>]. Therefore, we decided to use ChromHMM annotations as the ground truth in our models (further discussed in Discussion).</p>
      <fig position="float" id="pcbi.1009670.g002">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>CoRE-ATAC outperforms sequence-based enhancer prediction methods.</title>
          <p>CoRE-ATAC predictions were evaluated using held out test data (chromosomes 3 and 11). (<bold>A</bold>) ChromHMM state distributions for different cell types used in this study. ATAC-seq open chromatin maps correspond to a multitude of <italic toggle="yes">cis</italic>-RE functional states, corresponding to Active Promoter (AP), Promoter (P), Flanking Enhancer, (FE), Active Enhancer (AE), Enhancer (E), Genic Enhancer (GE), Transcribed (Tx), Insulator (I), Repressed (R) and Low Signal (LS). (<bold>B</bold>) Micro-average precision values (left) were calculated, summarizing the average precision values for individual class predictions for all cell types used in model training. A breakdown of individual class average precision scores is shown for K562 (right). (<bold>C</bold>) Combined confusion matrix of model predictions across all cell types used in model training. Note that models are predictive for all class labels: promoters (P), enhancers (E), insulators (I), and other (O). However, mispredictions were more frequently observed between enhancer and other functional classes. (<bold>D</bold>) Receiver operating characteristic (ROC) curves for different enhancer prediction models: CoRE-ATAC, PEAS, DeepSEA and LS-GKM and CoRE-ATAC’s sequence, signal, and signal+sequence (No PEAS features) models. Models were evaluated for predicting enhancer versus “other” classes for chr3 and chr11 of the GM12878, HSMM, K562, and CD14+ datasets. Note that CoRE-ATAC outperforms alternative methods.</p>
        </caption>
        <graphic xlink:href="pcbi.1009670.g002" position="float"/>
      </fig>
      <p>Using ChromHMM annotations in cognate cell types as class labels, CoRE-ATAC was trained on GM12878, K562, HSMM, and CD14<sup>+</sup>ATAC-seq samples and model performanceswere evaluated using held-out test data (i.e., regions within chromosomes 3 and 11 in the same samples) (<xref rid="pcbi.1009670.t002" ref-type="table">Table 2</xref>). After identifying a concordant set of 10 functional states to use as a ground truth based on in-house and Roadmap ChromHMM states (<xref rid="pcbi.1009670.s001" ref-type="supplementary-material">S1</xref> and <xref rid="pcbi.1009670.s002" ref-type="supplementary-material">S2</xref> Figs), we showed that among these, four states could be effectively discriminated from ATAC-seq maps (<xref rid="pcbi.1009670.s003" ref-type="supplementary-material">S3 Fig</xref>). We therefore annotated ATAC-seq peaks for three major functional <italic toggle="yes">cis</italic>-RE classes (promoters, enhancers, and insulators) using ChromHMM and combined other states into a fourth class, named “other” which captures states such as repressed, transcribed, and low signal/quiescent regions, covering ATAC-seq peaks that do not correspond to the three major <italic toggle="yes">cis</italic>-REs (Materials and Methods) (<xref rid="pcbi.1009670.s004" ref-type="supplementary-material">S4 Fig</xref>). For the remainder of our analyses, we focus on models utilizing these four functional states: promoter, enhancer, insulator, and other.</p>
      <table-wrap position="float" id="pcbi.1009670.t002">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Chromosomes &amp; number of examples for training, validation, and test data.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pcbi.1009670.t002" id="pcbi.1009670.t002g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Category</th>
                <th align="left" rowspan="1" colspan="1">Selected Chromosomes</th>
                <th align="left" rowspan="1" colspan="1">Promoters</th>
                <th align="left" rowspan="1" colspan="1">Enhancers</th>
                <th align="left" rowspan="1" colspan="1">Insulators</th>
                <th align="left" rowspan="1" colspan="1">Other</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Training</td>
                <td align="left" rowspan="1" colspan="1">1, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22</td>
                <td align="left" rowspan="1" colspan="1">42554</td>
                <td align="left" rowspan="1" colspan="1">55801</td>
                <td align="left" rowspan="1" colspan="1">13070</td>
                <td align="left" rowspan="1" colspan="1">41430</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Validation</td>
                <td align="left" rowspan="1" colspan="1">2, 10</td>
                <td align="left" rowspan="1" colspan="1">6663</td>
                <td align="left" rowspan="1" colspan="1">11361</td>
                <td align="left" rowspan="1" colspan="1">2565</td>
                <td align="left" rowspan="1" colspan="1">8650</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Testing</td>
                <td align="left" rowspan="1" colspan="1">3, 11</td>
                <td align="left" rowspan="1" colspan="1">6306</td>
                <td align="left" rowspan="1" colspan="1">10070</td>
                <td align="left" rowspan="1" colspan="1">2504</td>
                <td align="left" rowspan="1" colspan="1">7790</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p>CoRE-ATAC models evaluated on 4 cell types (<xref rid="pcbi.1009670.t001" ref-type="table">Table 1</xref>) had high micro-average precision (0.88–0.96) and micro-average F1 scores (0.80–0.92) across all samples with a combined accuracy of 84.20% (<xref rid="pcbi.1009670.g002" ref-type="fig">Fig 2B</xref> left and <xref rid="pcbi.1009670.g002" ref-type="fig">2C</xref>). Individual class performances also observed high average precision for all four classes of <italic toggle="yes">cis</italic>-REs (Figs <xref rid="pcbi.1009670.g002" ref-type="fig">2B</xref> right and <xref rid="pcbi.1009670.s005" ref-type="supplementary-material">S5</xref>), establishing that high precision/accuracy values from CoRE-ATACpredictions are not driven by predictions of a single functional class. However, we noted that most mis-predictions were between enhancer and “other” classes (<xref rid="pcbi.1009670.g002" ref-type="fig">Fig 2C</xref>). The “other” class is comprised of all other ChromHMM states including “transcribed”, “repressed” and “low signal” states, with the majority corresponding to the “low signal” state (<xref rid="pcbi.1009670.s006" ref-type="supplementary-material">S6 Fig</xref>).</p>
      <p>To benchmark the performance of CoRE-ATAC, we compared its performance with two sequence based methods: DeepSEA [<xref rid="pcbi.1009670.ref022" ref-type="bibr">22</xref>] and LS-GKM [<xref rid="pcbi.1009670.ref032" ref-type="bibr">32</xref>], and our previous neural network based approach PEAS [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>] using the same training and testing data for enhancer and “other” classes. CoRE-ATAC showed improvement over these alternative methods (Figs <xref rid="pcbi.1009670.g002" ref-type="fig">2D</xref>, <xref rid="pcbi.1009670.s007" ref-type="supplementary-material">S7A</xref>, and <xref rid="pcbi.1009670.s007" ref-type="supplementary-material">S7B</xref>) (average precision = 0.92, F1 score = 0.85) for held out test data), with PEAS following second in performance (average precision = 0.90, F1 score = 0.84). Methods based solely on DNA sequence performed similarly to one another for enhancer prediction (<xref rid="pcbi.1009670.s007" ref-type="supplementary-material">S7A and S7B Fig</xref>) (average precision = 0.80–0.81, F1 score = 0.65–0.77) but were not as effective as PEAS and CoRE-ATAC. The increased predictive performances of CoRE-ATAC and PEAS suggest that ATAC-seq signal (e.g., read/insert pileups) contains critical information for classifying <italic toggle="yes">cis</italic>-REs that cannot be captured from DNA sequence alone. Performances for predicting promoter and insulators revealed that promoters are easily predicted by all classifiers and that CTCF insulators are difficult to detect using ATAC-seq signal alone (<xref rid="pcbi.1009670.s007" ref-type="supplementary-material">S7C–S7F Fig</xref>). This analysis establishes that CoRE-ATAC improves upon DNA sequence-based approaches by capturing relevant and predictive features from the ATAC-seq signal.</p>
    </sec>
    <sec id="sec004">
      <title>CoRE-ATAC predicts <italic toggle="yes">cis</italic>-RE functionality across cell types</title>
      <p>We evaluated CoRE-ATAC’s ability to predict cis-RE function in 40 bulk ATAC-seq samples from different cell types including four primary cells (i.e., pancreatic islets, naïve CD8+ T, PBMC, CD4+ T) and three cell lines (MCF7, A549, EndoC beta cell line). These samples were not used in model training (held-out, <xref rid="pcbi.1009670.t001" ref-type="table">Table 1</xref>). Note that among these, MCF7 (breast cancer) and A549 (adenocarcinoma) are cancer cell lines; hence they have different cellular characteristics than the primary cells used in training. CoRE-ATAC models were highly predictive for cell types that were not utilized in model training, showing~0.80 micro-average precision and 0.80–0.92 micro-average F1 scores across all samples (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3A</xref>). The highest precision values were detected for promoters (~0.95), followed by enhancers (~0.76) (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3A</xref>). Insulator annotations were only available in 4 of the 7 cell types tested (MCF7, A549, CD4<sup>+</sup> T and islet), however, insulator states in islets were excluded from these analyses due to the poor quality of CTCF ChIP-seq data in islets (<xref rid="pcbi.1009670.s008" ref-type="supplementary-material">S8 Fig</xref>), which affected the performance assessment for islet samples. Among the remaining 3 cell types, known insulators (based on ChromHMM states) were predicted with high average precision (~0.78) (Figs <xref rid="pcbi.1009670.g003" ref-type="fig">3A</xref> and <xref rid="pcbi.1009670.s009" ref-type="supplementary-material">S9</xref> for islets). As expected, the majority of insulator predictions resided within CTCF ChIP-seq peaks (<xref rid="pcbi.1009670.s010" ref-type="supplementary-material">S10 Fig</xref>). To further show the functional relevance of CoRE-ATAC insulators that were either not annotated by ChromHMM (i.e., cell types that are missing insulator states) or misclassified when compared to ChromHMM insulators, we conducted de novo motif enrichment analysis using HOMER [<xref rid="pcbi.1009670.ref033" ref-type="bibr">33</xref>]. CTCF motif was the most enriched sequence for these loci with a very significant p-value (P-value &lt; 1e-27180) (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3B</xref>), suggesting that CoRE-ATAC predictions capture CTCF insulator sequences. It is possible that since CoRE-ATAC relies on CTCF binding motifs to detect insulators, it might mistake non-insulator CTCF sites as insulators.</p>
      <fig position="float" id="pcbi.1009670.g003">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>CoRE-ATAC can predict REs across cell-types.</title>
          <p>CoRE-ATAC was evaluated in 7 cell types using 40 samples that are not used in model training. (<bold>A</bold>) Average precision scores for predicting <italic toggle="yes">cis</italic>-REs. Micro-average precision was used to calculate class average scores. CoRE-ATAC is predictive across cell types and different functional classes with an exception of insulators in islets, which is due to CTCF ChIP-seq quality in islets. (<bold>B</bold>) De novo motif enrichment results for regions predicted as insulators by CoRE-ATAC but were not annotated as insulators by ChromHMM. Note that these regions are significantly enriched for the CTCF motif (0.983 similarity), suggesting that CoRE-ATAC insulator predictions are functionally relevant.(<bold>C</bold>) Distribution of CoRE-ATAC predictions. Prediction distributions are similar to those observed by ChromHMM state annotations. (<bold>D</bold>) Comparison of CoRE-ATAC to baseline/naive predictions based on thresholds for distance to TSS, MACS2 FDR, and number of CTCF motifs. CoRE-ATAC improves upon baseline performances. (<bold>E</bold>) CoRE-ATAC performances for i) predictions overlapping regions used in model training (O), and ii) predictions within regions that are on held-out test chromosomes (E). Note the performance similarity between these two prediction categories across all classes. (<bold>F</bold>) CoRE-ATAC model performances (top) and the average number of promoters and enhancers observed (bottom) by cell-type-specificity. We observed that CoRE-ATAC was more effective in predicting common promoters and cell-type-specific enhancers, for which we had more examples represented in the data. CoRE-ATAC’s ability to predict cell-type-specific enhancers demonstrates its usefulness for interrogating individual and cell-type-specific enhancers.</p>
        </caption>
        <graphic xlink:href="pcbi.1009670.g003" position="float"/>
      </fig>
      <p>As expected, functional annotation of ATAC-seq peaks from these 40 samples <italic toggle="yes">via</italic> CoRE-ATAC (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3C</xref>) were similar to state distributions observed with ChromHMM (<xref rid="pcbi.1009670.g002" ref-type="fig">Fig 2A</xref>). In addition, we studied whether functional predictions with CoRE-ATAC can outperform a naïve annotation approach using distance to transcription start site (TSS), MACS2 FDR, and number of CTCF motifs (Materials and Methods). CoRE-ATAC annotations outperformed these naïve annotation approaches (Figs <xref rid="pcbi.1009670.g003" ref-type="fig">3D</xref> and <xref rid="pcbi.1009670.s011" ref-type="supplementary-material">S11</xref>), observing ~0.58 Matthews correlation coefficient score for CoRE-ATAC compared to ~0.47 on the average across all samples. Matthews correlation coefficient was used to account for the fact that threshold-based approaches produce binary probabilities (i.e. 1.0 or 0.0) that can result in misleading average precision calculations.</p>
      <p>A potential pitfall in cross-cell-type model evaluations is the use of the same genomic regions (e.g., same chromosome) in both model training and testing [<xref rid="pcbi.1009670.ref034" ref-type="bibr">34</xref>]. When the same region (not the same genomic data) is used in training and testing, a model might perform well simply because it “remembers” the specific DNA sequences used during training. To study whether our model suffers from this pitfall, we utilized the two chromosomes that were excluded from model training (chromosomes 3 and 11) and compared cross cell type predictions for these two chromosomes with regions that overlapped loci used in model training and observed comparable predictive performances (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3E</xref>). These analyses suggest that CoRE-ATAC has learned a function from DNA sequence and chromatin accessibility signals that is transferable across genomic regions for predicting <italic toggle="yes">cis</italic>-RE functionality rather than learning to memorize specific DNA sequences.</p>
      <p>We further analyzed cross cell type performances by comparing enhancers versus other predictions of CoRE-ATAC with alternative models while incorporating cell types from 9 different tissues and cell types from ENCODE [<xref rid="pcbi.1009670.ref008" ref-type="bibr">8</xref>,<xref rid="pcbi.1009670.ref035" ref-type="bibr">35</xref>,<xref rid="pcbi.1009670.ref036" ref-type="bibr">36</xref>]: Body of Pancreas, Liver (Right Lobe), HepG2, Heart (Left Ventricle), Heart (Right Atrium), Transverse Colon, Stomach, Testis, and Thyroid. We observed that CoRE-ATAC outperformed alternative sequence-based methods(Mann Whitney P-Values &lt; 0.0096 for ROC AUC values) for enhancer prediction while promoters and CTCF insulators were predicted with high performances for the majority of classifiers (<xref rid="pcbi.1009670.s012" ref-type="supplementary-material">S12 Fig</xref>). Based on these performances, CoRE-ATAC is the best performing model for predicting enhancer activity in new cell types among the models tested.</p>
      <p>Finally, we evaluated CoRE-ATAC’s cross-cell-type performance by stratifying ATAC-seq peaks by their cell-specificityacross 7 cell types and compared prediction performances. CoRE-ATAC predicted common promoters with higher average precision than cell-type-specific promoters. Interestingly, CoRE-ATAC predicted cell-type-specific enhancers more effectively compared to common enhancers (mean average precision 0.70 versus 0.48), emphasizing the utilityof this method to study disease-relevant enhancers that are typically cell-type-specific [<xref rid="pcbi.1009670.ref002" ref-type="bibr">2</xref>,<xref rid="pcbi.1009670.ref003" ref-type="bibr">3</xref>] (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3F</xref> top). The prediction bias observed for cell-specific promoters is likely due to the number of elements used in model training given that the majority of promoters are common among cell types (<xref rid="pcbi.1009670.g003" ref-type="fig">Fig 3F</xref> bottom), whereas the majority of enhancers are cell-type-specific.</p>
    </sec>
    <sec id="sec005">
      <title>Core-ATAC models are robust to training with a low number of cell types</title>
      <p>We explored whether increasing the number of cell types could improve the performance of CoRE-ATAC. For this, we trained three different models for comparisons. The first model with 7 different cell types: GM12878, HSMM, Body of Pancreas, Stomach, Thyroid, Testis, and Transverse Colon. The second model was trained using the same cell types used previously, while including Heart (Left Ventricle) and Heart (Right Atrium). Finally, the third model was trained just as the second, but including Liver and HepG2 samples. We tested these models on held out cell types and chromosomes and determined that increasing the number of cell types had little impact for CoRE-ATAC’s predictive power (<xref rid="pcbi.1009670.s013" ref-type="supplementary-material">S13 Fig</xref>). The original cell types used by CoRE-ATAC are likely sufficient for training the models to learn the signatures of <italic toggle="yes">cis</italic>-REs present in ATAC-seq data.</p>
    </sec>
    <sec id="sec006">
      <title>Core-ATAC can predictenhancers that are captured <italic toggle="yes">via</italic> different assays</title>
      <p>Several methods have been established for experimentally identifying enhancer sequences. The FANTOM5 project [<xref rid="pcbi.1009670.ref037" ref-type="bibr">37</xref>,<xref rid="pcbi.1009670.ref038" ref-type="bibr">38</xref>] generated a databaseof enhancers for over a thousand tissues and cell lines using Cap Analysis of Gene Expression (CAGE) [<xref rid="pcbi.1009670.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1009670.ref025" ref-type="bibr">25</xref>], which identifies enhancers using the observation that balanced bidirectional capped transcripts correspond to active enhancers. More recently, massively parallel reporter assays (MPRA) [<xref rid="pcbi.1009670.ref027" ref-type="bibr">27</xref>] have enabled experimentally testing thousands of sequences in parallel for regulatory activity (i.e., promoters and enhancers) [<xref rid="pcbi.1009670.ref039" ref-type="bibr">39</xref>]. In particular, self-transcribing active regulatory region sequencing (STARR-seq) [<xref rid="pcbi.1009670.ref026" ref-type="bibr">26</xref>] identifies enhancers by cloning sequences downstream of a promoter that transcribes the enhancer sequence depending on its activity. Previous studies showed that ChromHMM captures these experimentally identified enhancers with high overlap/enrichment [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>,<xref rid="pcbi.1009670.ref040" ref-type="bibr">40</xref>]. To study whether CoRE-ATAC also detects enhancers identified by alternative methods, we first compared ChromHMM annotations and CoRE-ATAC predictions in MCF7, A549, CD4<sup>+</sup> T, and PBMC cell types to CAGE [<xref rid="pcbi.1009670.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1009670.ref025" ref-type="bibr">25</xref>] enhancers identified by the FANTOM5 project [<xref rid="pcbi.1009670.ref037" ref-type="bibr">37</xref>,<xref rid="pcbi.1009670.ref038" ref-type="bibr">38</xref>]. We observed that the majority of FANTOM enhancers overlapped with promoters and enhancers in both ChromHMM and CoRE-ATAC (Figs <xref rid="pcbi.1009670.g004" ref-type="fig">4A</xref> and <xref rid="pcbi.1009670.s014" ref-type="supplementary-material">S14A</xref> for test set chromosomes). CoRE-ATAC enhancer predictions showed significant overlap with FANTOM enhancers (Fisher’s exact test p-values for all cell types &lt;4.52e-59 for all chromosomes, &lt;5.29e-10 for test set chromosomes). The similarity between ChromHMM and CoRE-ATACfurther establishes that functional annotations <italic toggle="yes">via</italic> CoRE-ATAC using ATAC-seq data is a cost-effective alternative to annotations <italic toggle="yes">via</italic> ChromHMM that use multiple ChIP-seq assays.</p>
      <fig position="float" id="pcbi.1009670.g004">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>CoRE-ATAC predictions overlap with experimentally detected enhancers.</title>
          <p>(<bold>A</bold>) Overlap of FANTOM enhancer annotationswith CoRE-ATAC (C) and ChromHMM (H) predictions in MCF7, A549, CD4<sup>+</sup> T and PBMC samples. CoRE-ATAC predicted the majority of FANTOM enhancers as enhancers or promoters, recapitulating these experimentally identified enhancers. CoRE-ATAC annotations were similar toChromHMM annotations. (<bold>B</bold>) CoRE-ATAC predictions for active regulatory regions identified by STARR-seq in A549 cell line. The majority of active enhancers identified by STARR-seq were predicted as promoter or enhancer by CoRE-ATAC. (<bold>C</bold>) MIN6 MPRA log fold change values for genomic regions predicted as losing or gaining <italic toggle="yes">cis</italic>-RE function based on CoRE-ATAC probabilities for reference and alternative alleles. Significance for predicted loss and predicted gain categories was calculated using student’s t-test for MPRA log fold change values being less than or greater than 0 respectively. Significance comparing the predicted loss and predicted gain of MPRA fold change distributions was calculated using Mann-Whitney U test. We observed concordant direction of effect both for CoRE-ATAC predictions and MPRA activity levels when alternative and reference alleles are compared. (<bold>D</bold>) Genome browsers of 19 islet samples highlighting a loss of enhancer activity for rs11205653 (also highlighted in (<bold>C</bold>)) for the alternative allele (G). Values for enhancer and other represent the probability assigned to those classes of <italic toggle="yes">cis</italic>-REs by CoRE-ATAC. We observe that for 5 out of 7 individuals with the reference allele (TT) CoRE-ATAC predicted enhancer activity, reflecting ChromHMM reference annotations, while for the individuals with GT or GG alleles, we observed an enhancer activity loss for all but one individual based on CoRE-ATAC predictions.</p>
        </caption>
        <graphic xlink:href="pcbi.1009670.g004" position="float"/>
      </fig>
      <p>Next, to understand whether CoRE-ATAC could detect enhancers identified <italic toggle="yes">via</italic> MPRAs, we first compared enhancer predictions in A549 cells to enhancers identified from STARR-seq [<xref rid="pcbi.1009670.ref026" ref-type="bibr">26</xref>,<xref rid="pcbi.1009670.ref041" ref-type="bibr">41</xref>]. The majority of sequences that showed regulatory activity in this assay were predicted as enhancers (overlap significance calculated using Fisher’s exact test p-value &lt;3.247e-61 for all chromosomes, p-value &lt;6.367e-09 for test chromosomes) by CoRE-ATAC (Figs <xref rid="pcbi.1009670.g004" ref-type="fig">4B</xref> and <xref rid="pcbi.1009670.s014" ref-type="supplementary-material">S14B</xref>). We noted that a significant portion of STARR-seq enhancers (~33%) were predicted as promoters in our models and the majority of these regions were close to TSS (<xref rid="pcbi.1009670.s014" ref-type="supplementary-material">S14C and S14D Fig</xref>). In contrast, CoRE-ATAC enhancers overlapping STARR-seq active regions were more distal from the TSS (<xref rid="pcbi.1009670.s014" ref-type="supplementary-material">S14E and S14F Fig</xref>). CoRE-ATAC predictions resembled ChromHMM annotations for promoters and insulators (<xref rid="pcbi.1009670.s014" ref-type="supplementary-material">S14G and S14H Fig</xref>), 480 and 474 promoters, 26and 35 insulators for CoRE-ATAC and ChromHMM respectively (all chromosomes). However, ChromHMM has more information available allowing it to correctly annotate more enhancers (868 enhancers) than CoRE-ATAC (788 enhancers), which only uses ATAC-seq data.</p>
      <p>Regulatory activities of certain open chromatin regions are genetically modulated, which can be detected <italic toggle="yes">via</italic> chromatin accessibility quantitative trait loci (caQTL) analyses. Previously, we identified caQTLs from human islet samples (n = 19) [<xref rid="pcbi.1009670.ref007" ref-type="bibr">7</xref>] for which we generated an MPRA library to test and compare the regulatory activity of reference and alternative alleles forcaQTLs and other variants (n = 4293 SNPs) [<xref rid="pcbi.1009670.ref042" ref-type="bibr">42</xref>]. These data gave us the opportunity to test whether CoRE-ATAC predictions can detect genetically driven differences in the regulatory activity. Using CoRE-ATAC prediction probabilities from 19 islets (stratified based on genotypes), we identified 237 loci for which a gain or loss of enhancer activity was predicted based on individuals’ genotypes and CoRE-ATAC prediction probabilities using one-tailed point-biserial correlation p-values (<xref rid="sec009" ref-type="sec">Materials and Methods</xref>). Among these, 110 loci lost activity in the alternative allele, whereas 127 gained activity. For these sequences, we compared the regulatory activity from MPRA assays to the predicted gain/loss of activity from CoRE-ATAC and confirmed that the direction of effect coincides with the two analyses (Figs <xref rid="pcbi.1009670.g004" ref-type="fig">4C</xref> and <xref rid="pcbi.1009670.s015" ref-type="supplementary-material">S15</xref> for test chromosomes only). More specifically, loci with gain of function for the alternative allele based on CoRE-ATAC predictions had higher MPRA activity for thealternativeallele in comparison to the reference allele (i.e., fold change&gt;0). A similar concordance was observed for loci associated with loss of function for the alternative allele. For example, islet samples with the alternative allele for SNP rs11205653 (an islet caQTL) had lower enhancer probabilities compared to the samples with the reference allele, in agreement with the activity levels from the MPRA library for this locus (<xref rid="pcbi.1009670.g004" ref-type="fig">Fig 4D</xref>). Although CoRE-ATAC enhancer predictions were higher for individuals with TT genotype compared to individuals with GG and GT genotypes, we noted that individual-level heterogeneity in <italic toggle="yes">cis</italic>-RE activity levels within the same genotype. This heterogeneity likely stems from non-genetic factors including disease status (diabetic versus healthy) or other clinical information (i.e., medication use, sex, race). Together, these results and findings establish CoRE-ATAC’s ability to predict individual level variability in <italic toggle="yes">cis</italic>-RE activity including heterogeneity stemming from genetic variation.</p>
    </sec>
    <sec id="sec007">
      <title>Predicting disease-relevant enhancers from single nuclei ATAC-seq data</title>
      <p>Single nucleus ATAC-seq (snATAC-seq)reveals chromatin accessibility at single nucleus resolution and enables 1) interrogation of chromatin accessibility at the single cell level; 2) identifying epigenomic maps of rare cell types <italic toggle="yes">via</italic> unsupervised clustering methods [<xref rid="pcbi.1009670.ref013" ref-type="bibr">13</xref>]; 3) enabling the study of cell types within tissues without the need to sort cells. In light of this emerging technology, we applied CoRE-ATAC models (trained on bulk data) to predict cis-REs in snATAC-seq data. To test this, we predicted <italic toggle="yes">cis</italic>-RE functions from human PBMC snATAC data [<xref rid="pcbi.1009670.ref013" ref-type="bibr">13</xref>] by first clustering cells into 15 groups based on the similarity of their accessibility profiles (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5A</xref>). Comparisons with sorted immune cell bulk ATAC-seq data [<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>,<xref rid="pcbi.1009670.ref017" ref-type="bibr">17</xref>] revealed 7 distinct cell types corresponding to B, natural killer (NK), CD8<sup>+</sup> T, CD4<sup>+</sup> T, effector CD4<sup>+</sup> T, CD14<sup>+</sup>, and dendritic cells (DCs) (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5B</xref>). CoRE-ATAC models trained on bulk ATAC-seq data, predicted <italic toggle="yes">cis</italic>-REfunction in snATAC aggregate clusters (mean micro-average precision = 0.68, mean micro-average F1 score = 0.41) (Figs <xref rid="pcbi.1009670.g005" ref-type="fig">5C</xref> and <xref rid="pcbi.1009670.s016" ref-type="supplementary-material">S16</xref>), showing the flexibility and robustness of the method. Insulator predictions from snATAC-seq data were significantly enriched for CTCF/BORIS motifs (<xref rid="pcbi.1009670.s017" ref-type="supplementary-material">S17 Fig</xref>), confirming the biological relevance of these predictions.</p>
      <fig position="float" id="pcbi.1009670.g005">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.g005</object-id>
        <label>Fig 5</label>
        <caption>
          <title>Predicting functionality of REs from clusters of PBMC snATAC-seq data.</title>
          <p>(<bold>A</bold>) Single cell clusters annotated for 7 immune cell types. Two-pass clustering identified a total of 15 cell clusters which we annotated using hierarchical clustering with sorted bulk ATAC-seq data (shown in (<bold>B</bold>)) to identify 7 different immune cells corresponding to these clusters. (<bold>B</bold>) Hierarchical clustering of snATACclusters with bulk ATAC-seq data. Numbers and highlighted regions within the heatmap correspond to cell clusters and annotations in (<bold>A</bold>). 7 immune cell types were observed with both snATAC and bulk ATAC-seq samples. (<bold>C</bold>) (Top) Average precision values for predicting <italic toggle="yes">cis</italic>-RE function in snATAC for 6 annotated clusters with available ChromHMM states. Model performances suggest that CoRE-ATAC is an effective tool for interrogating <italic toggle="yes">cis</italic>-RE activity from snATAC data. (Bottom) Mean average precision and average F1 score values for promoters, enhancers, insulators and other. (<bold>D</bold>) Percent of super enhancers detected among CoRE-ATAC enhancers, demonstratingCoRE-ATAC’s ability to identify cell-type-specific enhancers that are most relevant to disease. (<bold>E</bold>) GREGOR SNP enrichment analysis highlighting selected diseases whose SNPs were significantly enriched within the enhancer elements predicted by CoRE-ATAC. Enhancers from PBMCsnATAC-seq were significantly enriched for SNPs associated with immune diseases. (<bold>F</bold>) Genome browser view of <italic toggle="yes">IL7R</italic> for bulk ATAC and snATAC samples for CD4<sup>+</sup>T cells. ATAC-seq read profiles and CoRE-ATAC predictions between snATAC and bulk ATAC were found to be similar to one another, demonstrating CoRE-ATAC as a robust method for <italic toggle="yes">cis</italic>-RE predictions. Red represents promoter predictions, yellow represent enhancer predictions, and gray represent “other” predictions from CoRE-ATAC.</p>
        </caption>
        <graphic xlink:href="pcbi.1009670.g005" position="float"/>
      </fig>
      <p>Similar to enhancer predictions in bulk ATAC-seq, CoRE-ATAC enhancer predictions in snATAC clusters also included cell-specific enhancers for immune cell subsets within PBMCs (<xref rid="pcbi.1009670.s018" ref-type="supplementary-material">S18 Fig</xref>). Cell-type specific peaks identified by CoRE-ATAC in these immune cells significantly overlapped with cell-specific enhancers inferred from ChromHMM annotations of relevant immune cell types (<xref rid="sec009" ref-type="sec">Materials and Methods</xref>) (<xref rid="pcbi.1009670.s019" ref-type="supplementary-material">S19 Fig</xref>). Super enhancers tend to be cell type-specific and often overlap disease-relevant SNPs [<xref rid="pcbi.1009670.ref002" ref-type="bibr">2</xref>]. We therefore further studied CoRE-ATAC’s ability to identify super enhancers in these 7 immune cell types obtained from SEdb [<xref rid="pcbi.1009670.ref043" ref-type="bibr">43</xref>]. On average, ~81% of super enhancers were captured by CoRE-ATAC enhancer predictions within their respective cell types for single cell predictions (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5D</xref>), which was comparable to the detection rate from bulk ATAC-seq data which captured ~76% of super enhancers. The ability to identify cell-specific enhancers from snATAC-seq data is instrumental for studying rare cell populations and clinical samples.</p>
      <p>We further assessed CoRE-ATAC’s ability to identify disease-relevant enhancers by conducting GWAS SNP enrichment analyses using GREGOR [<xref rid="pcbi.1009670.ref044" ref-type="bibr">44</xref>].For this analysis we comparedCoRE-ATAC enhancer prediction in the 7 cell types inferred from snATAC-seq data with enhancers predicted from bulk ATAC-seq data (A549, MCF7, islets, EndoC, CD4<sup>+</sup> T and naïve CD8<sup>+</sup> T). Immune cell enhancers predicted from snATAC-seq data were enriched in diseases related to the immune system (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5E</xref>). For example, B cell enhancers were the most significantly enriched for variants linked to Systemic Lupus, a disease characterized by dysfunctions in B cells [<xref rid="pcbi.1009670.ref045" ref-type="bibr">45</xref>]. Islet enhancers were most significantly enriched for Type 2 Diabetes and Fasting Blood Glucose as expected, while T cell were most significantly enriched in immune diseases (e.g., Type 1 Diabetes). Overall, enhancer predictions were enriched in diseases that were the most relevant to their respective cell types, confirming that CoRE-ATAC can infer cell-specific enhancers. Immune cell enhancers predicted from snATAC-seq data were enriched in diseases related to the immune system (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5E</xref>) and were the most enriched among the other classes of predictions (<xref rid="pcbi.1009670.s020" ref-type="supplementary-material">S20 Fig</xref>) as expected.</p>
      <p>Chromatin accessibility profiles of snATAC-seq clusters resembled that of bulk data from sorted cells, enabling CoRE-ATAC to effectively predict <italic toggle="yes">cis</italic>-RE function from snATAC-seq data, e.g., the locus around the <italic toggle="yes">IL7R</italic> (an important gene for T cell aging [<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>]) in CD4<sup>+</sup> T cells both in bulk and single cell maps (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5F</xref>). Despite similarities between sorted cell and single cell cluster epigenomes, the efficacy of CoRE-ATAC on snATAC-seq data was not given due to the differences in how cells areprocessed (i.e., FACS sorted cells versus single cell clusters) as well as differences between bulk and snATAC-seq libraries (depth, peak sizes, read distributions etc.). Our analyses have demonstrated that CoRE-ATAC models built from bulk data can effectively predict <italic toggle="yes">cis</italic>-RE function in snATAC-seq data, which is essential for the analyses of future snATAC-seq maps.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec008">
    <title>Discussion</title>
    <p>Recent advances in ATAC-seq profiling and single cell genomics revolutionized the epigenomics field by enabling the generation of chromatin accessibility maps from small starting material, even at single cell resolution. Due to these advances, epigenomic maps of human cells/tissues from many individuals are being generated at an unprecedented rate, including our own studies, to study how epigenomic landscapes change with age, diseases, and upon in-vivo and in-vitro activation [<xref rid="pcbi.1009670.ref007" ref-type="bibr">7</xref>,<xref rid="pcbi.1009670.ref011" ref-type="bibr">11</xref>,<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>–<xref rid="pcbi.1009670.ref019" ref-type="bibr">19</xref>]. These epigenomic maps are instrumental for inferring <italic toggle="yes">cis</italic>-REs from clinically relevant samples. CoRE-ATAC harnesses the power of deep learning to integrate chromatin accessibility maps with DNA sequence and effectively predicts the functionality of <italic toggle="yes">cis</italic>-REs (i.e., promoters, enhancers, insulators) across diverse cell types and individuals. We extensively evaluated CoRE-ATAC’s efficacy to predict <italic toggle="yes">cis</italic>-RE function across multiple cell types including those that are not used in model training. We established that CoRE-ATAC is an effective method for classifying the functional state of <italic toggle="yes">cis</italic>-REs, in new cell types (i.e., cell types that are missing reference annotations) and in snATAC-seq data.</p>
    <p>One of the unique features of CoRE-ATAC is its ability to integrate an individual’s genotype with chromatin accessibility maps by inferring the genotype from ATAC-seq read alignments. CoRE-ATAC accomplishes this with a sequence encoder that uses the frequency of ATAC-seq reads observing a specific base-pair at a genomic position instead of solely using a one hot encoding of the reference genome, separating our method from existing ones that use the commonly used one hot-encoding approach. If genotype data (e.g., SNP arrays) are available for an individual, one can also leverage this information in CoRE-ATAC predictions by providing a reference specific to the individual. Genotype-aware methods can be effective in predicting the annotation and activityof <italic toggle="yes">cis</italic>-REs whose activity is modulated by genetic variation (e.g., caQTLs [<xref rid="pcbi.1009670.ref004" ref-type="bibr">4</xref>–<xref rid="pcbi.1009670.ref007" ref-type="bibr">7</xref>]). In alignment with this, we demonstrated that CoRE-ATAC predictions from individual islet epigenomes aligned with enhancer loss/gain between alleles inferred from MPRA assays. CoRE-ATAC’s ability to improve enhancer predictions at the individual level is studied at islet caQTLs, i.e., regions for which variation at the chromatin accessibility levels are associated with the genetic variation. Hence, the good performance of CORE-ATAC for these loci stem from both ATAC-seq signal as well as the underlying sequence since these two modalities are correlated with each other.</p>
    <p>CoRE-ATAC also established a foundation for inferring functional annotations from snATAC-seq clusters, which can be useful to study rare cell populations that can be identified from these assays. For this analysis, we used CoRE-ATAC models trained on bulk data due to current limitations on the availability of snATAC-seq data that coincide with existing ChromHMM/<italic toggle="yes">cis</italic>-RE annotations. Although models from bulk data were effective in predicting functionality of <italic toggle="yes">cis</italic>-REs from single cell data, models built from snATAC-seq data might further improve the predictive performance. In the future, as more snATAC-seq data becomes available for more samples and more diverse cell types with established ChromHMM and CTCF insulator states, a CoRE-ATAC model can be trained solely on snATAC-seq data, potentially resulting in better classification performances for the purposes of annotating rare cell populations. Our predictions from snATAC-seq data were conducted at the cluster level. Given the sparsity of chromatin accessibility information at the individual single cell level (open in both alleles, open in one allele, closed), predicting functionality at the single cell level will remain a challenge.</p>
    <p>Although CoRE-ATAC can effectively predict several functional classes of cis-REs, it has several limitations. First, CoRE-ATAC is limited to discriminating promoters, enhancers, and insulators, while categorizing the remaining open chromatin regions as ‘Other’. The ‘Other’ category includes multiple ChromHMM states (i.e., “repressed”, “transcribed”, “low signal”). Data features that we extract from chromatin accessibility maps and DNA sequence alone may not be sufficient to further annotate these loci. Second, despite the fact that CoRE-ATAC can capture enhancer activity in an individualized manner, since CoRE-ATAC uses both ATAC-seq maps and DNA sequence for predictions, it may sometimes fail to learn the importance of DNA sequences that are especially correlated with ATAC-seq signal patterns (e.g., caQTLs). Hence, it can fail to detect SNP effects on chromatin accessibility levels; more appropriate methods should be used to detect these effects [<xref rid="pcbi.1009670.ref005" ref-type="bibr">5</xref>]. Finally, CoRE-ATAC was trained using chromatin states defined by ChromHMM [<xref rid="pcbi.1009670.ref010" ref-type="bibr">10</xref>], which is another computational inference method. ChromHMM utilizes more and different types of data (i.e., multiple ChIP-seq assays) and does not use ATAC-seq maps to infer different chromatin states. The unsupervised approach of ChromHMM identifies clusters of genomic regions that have similar combinations of transcription factor/histone modification marks which can then be annotated using domain knowledge (e.g., states with H3K4me1, H3K27ac are likely enhancers). Although ChromHMM states are not directly and experimentally established cis-RE functions, they have multiple advantages over alternatives for class labeling in our machine learning models: 1) ChromHMM profiles are genomewide providing many examples for model training, 2) ChromHMM states are available for many different cell types, enabling training and testing models across many cell/tissue types, and 3) ChromHMM states are well studied and functionally validated [<xref rid="pcbi.1009670.ref046" ref-type="bibr">46</xref>], making these annotations high-quality references, despite being computational inferences. In terms of capturing enhancer function, we previously showed that when overlapping ChromHMM enhancers with FANTOM [<xref rid="pcbi.1009670.ref037" ref-type="bibr">37</xref>,<xref rid="pcbi.1009670.ref038" ref-type="bibr">38</xref>] and P300 [<xref rid="pcbi.1009670.ref030" ref-type="bibr">30</xref>,<xref rid="pcbi.1009670.ref031" ref-type="bibr">31</xref>] enhancers, ChromHMM captured the majority of both of these sets of enhancers [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>]. Another study compared ChromHMM with STARR-seq enhancers, and showed that STARR-seq enhancers [<xref rid="pcbi.1009670.ref026" ref-type="bibr">26</xref>] were significantly enriched for ChromHMM enhancer states [<xref rid="pcbi.1009670.ref040" ref-type="bibr">40</xref>]. We therefore decided that ChromHMM annotations were the most comprehensive functional annotations for training our deep learning models.</p>
    <p>CoRE-ATAC is widely applicable for inferring <italic toggle="yes">cis</italic>-RE function from ATAC-seq and further improves upon naïve methods as well as existing machine-learning models (Figs <xref rid="pcbi.1009670.g002" ref-type="fig">2D</xref> and <xref rid="pcbi.1009670.g003" ref-type="fig">3B</xref>) through its ability to leverage ATAC-seq signal information. Although model training is a computationally expensive process, requiring GPUs to train in a timely manner, using these models for predictions is much faster, requiring a little over 2 minutes (excluding the time to load the data into memory) to functionally annotate <italic toggle="yes">cis</italic>-REs for 75000 loci using a 2.3 GHz 8-Core Intel Core i9 processor (<xref rid="pcbi.1009670.s021" ref-type="supplementary-material">S21 Fig</xref>). Our in-depth performance analyses suggest thatCoRE-ATAC can be widely used, even with limited computational resources, to improve the functional annotations of ATAC-seq <italic toggle="yes">cis</italic>-RE maps. To promote the widespread use of our predictive model we have made the CoRE-ATAC code and pre-trained model freely available on GitHub (<ext-link xlink:href="https://github.com/UcarLab/CoRE-ATAC" ext-link-type="uri">https://github.com/UcarLab/CoRE-ATAC</ext-link>).</p>
  </sec>
  <sec sec-type="materials|methods" id="sec009">
    <title>Materials and methods</title>
    <sec id="sec010">
      <title>Machine learning architecture</title>
      <p>CoRE-ATAC utilizes both data encoded in the deep learning framework and features extracted using our previous method PEAS [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>]. These two feature sets are provided as two separate inputs into amachine learning model implemented using Keras [<xref rid="pcbi.1009670.ref047" ref-type="bibr">47</xref>] (version 2.2.4) and Tensorflow [<xref rid="pcbi.1009670.ref048" ref-type="bibr">48</xref>] libraries. The deep learning component uses four convolutional layer blocks that are trained with a batch size of 32. Each block consists of i) a 1D convolutional neural network (CNN) layer (window size = 19, stride = 1), ii) a batch normalization layer, iii) a second 1D CNN layer (window size = 19, stride = 1) iv) a max pooling layer (pool size = 2, stride = none) and v) a second batch normalization layer, in this order (<xref rid="pcbi.1009670.g001" ref-type="fig">Fig 1</xref>). The first two blocks of convolutional layer units utilize 256 filters while the final two blocks utilize 512 filters. Both the deep learning component and the PEAS component of the model are trained separately using their own dense neural network layer with n = 2048 nodes. For each component, default initialization was used to train the models without any prior knowledge. The outputs of these dense layers are then saved, concatenated, and provided as input into a combined dense layer with n = 512 nodes before classifying <italic toggle="yes">cis</italic>-REs in the final output dense layer using the Adam [<xref rid="pcbi.1009670.ref049" ref-type="bibr">49</xref>] optimization methodwith the default learning rate (0.001). CNN layer window sizes, number of filters, and number of dense layer nodes were selected based on the best parameters observed during model tuning.</p>
    </sec>
    <sec id="sec011">
      <title>ATAC-seq data encoders</title>
      <p>We implemented a novel ATAC-seq data encoder that takes as input: paired-end reads, peaks, and the reference genome (or a personalized genome reflecting an individual’s genetic variation) to generate one 10x600 matrix per peak. Rows represent DNA sequence and ATAC-seq signal data, while columns represent the 300 base-pair positions downstream and upstream from the peak center (<xref rid="pcbi.1009670.g001" ref-type="fig">Fig 1</xref>). Details of this matrix are explained below:</p>
      <list list-type="simple">
        <list-item>
          <p><bold><italic toggle="yes">Rows 1–4</italic>:</bold> The 0–1 normalized frequency of observing 1) adenine (A), 2) cytosine (C), 3) guanine (G), or 4) thymine (T) from ATAC-seq read pileups, which is calculated when there is enough read coverage (n &gt; = 10). For low coverage loci; the frequency reduces to a one-hot encoding, representing the corresponding nucleotide in the reference genome.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Row 5</italic>:</bold> The number of insert pileups within the 600 base-pair window, where each position is z-standardized with respect to pileups across all peaks for that position.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Rows 6 and 7</italic>:</bold> The number of 5’ (row 6) and 3’ (row 7) cuts at a given position (z-standardized). Savitzky-Golay smoothing filter [<xref rid="pcbi.1009670.ref050" ref-type="bibr">50</xref>] is applied with a window size of 15 to account for an increase in the number of cuts across multiple positions in close proximity due to sequencing depth.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Rows 8 and 9</italic>:</bold> The median fragment length for 5’ and 3’ cut site, applying the same standardization and smoothing used for rows 6/7.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Row 10</italic>:</bold> The original peak region, setting values to 1 if a base-pair position is within the peak and 0 otherwise. This allows for distinguishing between peaks that are in close proximity to one another and providing an indicator of the most relevant positions.</p>
        </list-item>
      </list>
      <p>In all analyses, peaks used for data encoding were called with MACS2 [<xref rid="pcbi.1009670.ref051" ref-type="bibr">51</xref>] using parameters “-f BAMPE—nomodel”. Duplicates were kept only in the snATAC-seq data analyses using the “—keep-dup all” option.</p>
    </sec>
    <sec id="sec012">
      <title>ATAC-seq data processing</title>
      <p>Paired end ATAC-seq reads were processed using ATAC-seq pipeline available at <ext-link xlink:href="https://github.com/UcarLab/ATAC-seq" ext-link-type="uri">https://github.com/UcarLab/ATAC-seq</ext-link>. First, read adapters were trimmed using Trimmomatic [<xref rid="pcbi.1009670.ref052" ref-type="bibr">52</xref>] (version 0.33). Next, reads were aligned to the hg19 reference genome using BWA MEM [<xref rid="pcbi.1009670.ref053" ref-type="bibr">53</xref>] (version 0.7.10-r789 for GM12878, CD14<sup>+</sup>, and islets, version 0.7.12-r1039 for all other samples). Finally, duplicates were marked using the Picard Toolkit [<xref rid="pcbi.1009670.ref054" ref-type="bibr">54</xref>] (version 2.8.1 for EndoC, version 1.95 for all other samples) and removed. snATAC-seq data was processed using CellRangerATAC (version 1.2) using default parameters.</p>
    </sec>
    <sec id="sec013">
      <title>Ground truth selection&amp; model training</title>
      <p>CoRE-ATAC was trained on ATAC-seq data from 4 different cell types: GM12878 [<xref rid="pcbi.1009670.ref011" ref-type="bibr">11</xref>] (GSE47753), K562 [<xref rid="pcbi.1009670.ref019" ref-type="bibr">19</xref>] (GSE121993), HSMM [<xref rid="pcbi.1009670.ref015" ref-type="bibr">15</xref>] (GSE109828, “54–1” at time 0), and CD14<sup>+</sup> monocytes [<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>] (EGAS00001002605) (<xref rid="pcbi.1009670.t001" ref-type="table">Table 1</xref>). Class labels were assigned by co-analyzing 15-state ChromHMM [<xref rid="pcbi.1009670.ref010" ref-type="bibr">10</xref>] models generated in these cell types with corresponding 18-state Roadmap [<xref rid="pcbi.1009670.ref009" ref-type="bibr">9</xref>] ChromHMM annotations. 15 state ChromHMM models were trained for each cell type independently using H3K4me1, H3K4me3, H3K27ac, H3K27me3, H3K36me3, H3K9me3 and CTCF ChIP-seq data from ENCODE [<xref rid="pcbi.1009670.ref008" ref-type="bibr">8</xref>] (<ext-link xlink:href="https://genome.ucsc.edu/ENCODE/index.html" ext-link-type="uri">https://genome.ucsc.edu/ENCODE/index.html</ext-link>). Hierarchical clustering of emission probabilities revealed 10 distinct clusters (<xref rid="pcbi.1009670.s001" ref-type="supplementary-material">S1 Fig</xref>) corresponding to active promoters, promoters, flanking enhancers, active enhancers, enhancers, genic enhancers, transcribed, insulator, repressed, and low signal states. Preliminary machine learning models were trained using the 10 clusters identified and peaks were selected based on their concordance with Roadmap [<xref rid="pcbi.1009670.ref009" ref-type="bibr">9</xref>] 18 state models (<xref rid="pcbi.1009670.s002" ref-type="supplementary-material">S2 Fig</xref>) in order to select the best examples for model training. Performance evaluations on the 10-state models revealed that only 4 major classes of <italic toggle="yes">cis</italic>-REs could be effectively predicted from such models across all cell types: promoter, enhancer, insulator and other classes (<xref rid="pcbi.1009670.s003" ref-type="supplementary-material">S3 Fig</xref>). Based on these results, we focused on training models with these 4 major classes and selected peaks using a wider range of concordance with Roadmap states (<xref rid="pcbi.1009670.s004" ref-type="supplementary-material">S4 Fig</xref>).</p>
      <p>While training CoRE-ATAC, we envisioned two use case scenarios for annotations 1) use of a single ATAC-seq sample; 2) use of a set of samples (i.e., multiple islet ATAC-seq samples) co-analyzed together. In the latter case, consensus peaks would be obtained from multiple samples and need to be annotated. In our experiments using consensus peaks, we noted that some “Other” regions are not called as peaks in all the samples, although they were among the consensus peaks. This could reflect individual-level heterogeneity and/or noise in either the data or peak calling step. To train a model that is robust to such instances, we incorporated non-peak regions for half of the samples (3 out of 6): HSMM, CD14+ Sample 2, and K562 replicate 2. Non-peak regions annotated as “Other” were selected among the consensus peaks that are not called as a peak in that cell type. Normalization steps are performed on each sample individually when encoding the data. Importantly, to not overwhelm the model with non-peak examples (since some of it could be noise), we restricted these examples to be at most 25% of all “Other” regions in that sample. In total, only 2,551 out of 57,870 (~4.4%) “Other” cases were such non-peaks. This step was implemented to help classify instances of non-peaks from a sample in case they are introduced to the algorithm, (i.e., <italic toggle="yes">via</italic> consensus peak data analyses.)</p>
      <p>Deep learning and PEAS components of CoRE-ATAC were initially trained separately to handle different rates of overfitting observed between the two models (overfitting evaluated using training and validation loss). Parameter tuning was performed in this stage of training to adjust i) the number of filters, ii) convolutional layer window size, iii) number of convolutional blocks, and iv) number of nodes within dense layers (where applicable) using held out validation data (i.e., ATAC-seq peaks in chromosomes 2 and 10) (<xref rid="pcbi.1009670.t002" ref-type="table">Table 2</xref>). Individually, each component achieved 82.56% and 79.25% accuracy on held out validation data for deep learning and PEAS components respectively using the best observed parameters for minimizing the validation loss. We then combined these models into a single unified model by concatenating deep learning and PEAS components with a concatenation layer, for a final round of model training.</p>
    </sec>
    <sec id="sec014">
      <title>Model tuning</title>
      <p>Hyperparameter selection was performed on i) the 1D convolution kernel size {9, 11, 19, 21}, ii) the number of convolutional layer block {3,4,5}, iii) intermediate dense layer size {1024, 2048, 4096} and iv) and the number of convolutional layer filters {32, 128, 256} where for each block the first two convolutional layers were set to the initial filter size and then doubled for the remaining two convolutional layers. Due to the long training time on these models, not every parameter combination (108 total) was tested. Instead, different parameters were tested one by one, and the best performing value for the parameter was kept. It is therefore possible that a more rigorous search for optimal hyperparameters could further improve CoRE-ATAC’s performance.</p>
    </sec>
    <sec id="sec015">
      <title>Model evaluation</title>
      <p>To test the performance of CoRE-ATAC on datasets and cell types that were not used in model training, we initially predicted <italic toggle="yes">cis</italic>-REs in ATAC-seq data obtained for 7 different cell types: MCF7 [<xref rid="pcbi.1009670.ref016" ref-type="bibr">16</xref>] (GSE97583) (n = 2), Naïve CD8<sup>+</sup> T [<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>,<xref rid="pcbi.1009670.ref017" ref-type="bibr">17</xref>] (GSE118189 &amp; EGAS00001002605) (n = 10), Peripheral Blood Mononuclear Cells (PBMCs) [<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>,<xref rid="pcbi.1009670.ref017" ref-type="bibr">17</xref>] (EGAS00001002605) (n = 6), CD4<sup>+</sup> T [<xref rid="pcbi.1009670.ref011" ref-type="bibr">11</xref>] (GSE47753) (n = 1), A549 [<xref rid="pcbi.1009670.ref055" ref-type="bibr">55</xref>] (GSE117089) (n = 1), pancreatic islets [<xref rid="pcbi.1009670.ref007" ref-type="bibr">7</xref>] (SRP117935) (n = 19) and EndoCbeta cell line [<xref rid="pcbi.1009670.ref018" ref-type="bibr">18</xref>] (GSE118588) (n = 1) (<xref rid="pcbi.1009670.t001" ref-type="table">Table 1</xref>). We later measured the performance of CoRE-ATAC on an additional 9 cell types from ENCODE [<xref rid="pcbi.1009670.ref008" ref-type="bibr">8</xref>,<xref rid="pcbi.1009670.ref035" ref-type="bibr">35</xref>,<xref rid="pcbi.1009670.ref036" ref-type="bibr">36</xref>]: HEPG2 [<xref rid="pcbi.1009670.ref056" ref-type="bibr">56</xref>] (ENCSR888GEN), Heart (Right Atrium) [<xref rid="pcbi.1009670.ref057" ref-type="bibr">57</xref>] (ENCSR525XSO), Heart (Left Ventricle) [<xref rid="pcbi.1009670.ref058" ref-type="bibr">58</xref>] (ENCSR025UEI), Testis [<xref rid="pcbi.1009670.ref059" ref-type="bibr">59</xref>] (ENCSR493GDU), Body of Pancreas [<xref rid="pcbi.1009670.ref060" ref-type="bibr">60</xref>] (ENCSR002JUR), Stomach [<xref rid="pcbi.1009670.ref061" ref-type="bibr">61</xref>] (ENCSR949WGV), Liver (Right lobe) [<xref rid="pcbi.1009670.ref062" ref-type="bibr">62</xref>] (ENCSR228KEB), Thyroid [<xref rid="pcbi.1009670.ref063" ref-type="bibr">63</xref>] (ENCSR646GBV), and Transverse Colon [<xref rid="pcbi.1009670.ref064" ref-type="bibr">64</xref>] (ENCSR654ORD). Model performances were evaluated using ChromHMM states in each cell type.</p>
    </sec>
    <sec id="sec016">
      <title>ChromHMM annotations for model evaluation</title>
      <p>For the majority of datasets, 15 state ChromHMM models were trained using H3K4me1, H3K4me3, H3K27ac, H3K27me3, H3K36me3, H3K9me3, and CTCF (when available) ChIP-seq data obtained from public repositories (<xref rid="pcbi.1009670.t003" ref-type="table">Table 3</xref>). For the remainder, ChromHMM states were used directly from their respective studies for EndoC [<xref rid="pcbi.1009670.ref018" ref-type="bibr">18</xref>] and the additional cell types identified for snATAC-seq clusters (closest references) which were obtained from Roadmap [<xref rid="pcbi.1009670.ref009" ref-type="bibr">9</xref>] (<ext-link xlink:href="https://egg2.wustl.edu/roadmap/web_portal/" ext-link-type="uri">https://egg2.wustl.edu/roadmap/web_portal/</ext-link>, 18 state models): B Cells (E032), NK Cells (E046), CD8<sup>+</sup> T (E048, Note: Memory CD8<sup>+</sup> T was selected as the closest reference), and Effector CD4<sup>+</sup> T (E043, Note: CD4+, CD25-,Th was selected as the closest reference). Recalled ChromHMM states were converted to the 4 major class labels used by CoRE-ATAC based on emission probability correlations with the 10 cluster previously identified (<xref rid="pcbi.1009670.s001" ref-type="supplementary-material">S1 Fig</xref>). The final ChromHMM 4 state labels are annotated in <xref rid="pcbi.1009670.s008" ref-type="supplementary-material">S8 Fig</xref> EndoC states (using state labels from the study [<xref rid="pcbi.1009670.ref018" ref-type="bibr">18</xref>])were converted based on the following: promoters were mapped from states labeled as 1_Active_TSS, 2_Weak_TSS, and 14_Bivalent_poised_TSS, enhancers were mapped from states labeled as 8_Genic_enhancer, 9_Active_enhancer_1, 10_Active_enhancer_2, and 11_Weak_enhancer, and other were mapped from states labeled as 5_Strong_transcription, 6_Weak_transcription, 16_Repressed_polycomb, 17_Weak_repressed_polycomb, and 18_Quiescent_low_signal. For 18 state models used directly from Roadmap [<xref rid="pcbi.1009670.ref009" ref-type="bibr">9</xref>]: promoters were mapped from states labeled as 1_TssA, 2_TssFlnk, enhancers were mapped from states labeled as 7_EnhG1, 8_EnhG2, 9_EnhA1, 10_EnhA2, and 11_EnhWk, and other were mapped from states labeled as 5_Tx, 6_TxWk, 12_ZNF/Rpts, 13_Het, 16_ReprPC, 17_ReprPCW, 18_Quies. EndoC and Roadmap ChromHMM data did not include CTCF insulators; hence some of the insulators in these cell types are likely mislabeled as other states. This is a limitation of using CoRE-ATAC on these datasets.</p>
      <table-wrap position="float" id="pcbi.1009670.t003">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009670.t003</object-id>
        <label>Table 3</label>
        <caption>
          <title>ChromHMM References.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pcbi.1009670.t003" id="pcbi.1009670.t003g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Cell Type</th>
                <th align="left" rowspan="1" colspan="1">Database</th>
                <th align="left" rowspan="1" colspan="1">Data Accession Id/URL</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CD14<sup>+</sup></td>
                <td align="left" rowspan="1" colspan="1">ENCODE (UCSC)</td>
                <td align="left" rowspan="1" colspan="1">
                  <ext-link xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/" ext-link-type="uri">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">K562</td>
                <td align="left" rowspan="1" colspan="1">ENCODE (UCSC)</td>
                <td align="left" rowspan="1" colspan="1">
                  <ext-link xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/" ext-link-type="uri">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">HSMM</td>
                <td align="left" rowspan="1" colspan="1">ENCODE (UCSC)</td>
                <td align="left" rowspan="1" colspan="1">
                  <ext-link xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/" ext-link-type="uri">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">GM12878</td>
                <td align="left" rowspan="1" colspan="1">ENCODE (UCSC)</td>
                <td align="left" rowspan="1" colspan="1">
                  <ext-link xlink:href="http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/" ext-link-type="uri">http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Naïve CD8<sup>+</sup> T</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR465PPP</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MCF7</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR247DVY</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">A549</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR797CXN</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CD4+ T</td>
                <td align="left" rowspan="1" colspan="1">GEO</td>
                <td align="left" rowspan="1" colspan="1">GSE17312 (Histone Marks) [<xref rid="pcbi.1009670.ref065" ref-type="bibr">65</xref>], GSE12889 (CTCF) [<xref rid="pcbi.1009670.ref066" ref-type="bibr">66</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PBMC</td>
                <td align="left" rowspan="1" colspan="1">GEO</td>
                <td align="left" rowspan="1" colspan="1">GSE16368 (from TC015) [<xref rid="pcbi.1009670.ref065" ref-type="bibr">65</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Pancreatic Islets</td>
                <td align="left" rowspan="1" colspan="1">GEO</td>
                <td align="left" rowspan="1" colspan="1">GSE51312 [<xref rid="pcbi.1009670.ref003" ref-type="bibr">3</xref>], GSE23784 [<xref rid="pcbi.1009670.ref067" ref-type="bibr">67</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">EndoC</td>
                <td align="left" rowspan="1" colspan="1">GEO</td>
                <td align="left" rowspan="1" colspan="1">GSE118588 [<xref rid="pcbi.1009670.ref018" ref-type="bibr">18</xref>]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Heart (Right Atrium)</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR525XSO</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Heart (Left Ventricle)</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR025UEI</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Testis</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR493GDU</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Body of Pancreas</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR002JUR</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Stomach</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR949WGV</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Liver (Right lobe)</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR228KEB</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Thyroid</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR646GBV</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Transverse Colon</td>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" rowspan="1" colspan="1">ENCSR654ORD</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">B Cells</td>
                <td align="left" rowspan="1" colspan="1">Roadmap</td>
                <td align="left" rowspan="1" colspan="1">E032</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NK Cells</td>
                <td align="left" rowspan="1" colspan="1">Roadmap</td>
                <td align="left" rowspan="1" colspan="1">E046</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Memory CD8<sup>+</sup> T</td>
                <td align="left" rowspan="1" colspan="1">Roadmap</td>
                <td align="left" rowspan="1" colspan="1">E048</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CD4<sup>+</sup>, CD25<sup>-</sup>,Th</td>
                <td align="left" rowspan="1" colspan="1">Roadmap</td>
                <td align="left" rowspan="1" colspan="1">E043</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">ENCODE (UCSC)</td>
                <td align="left" colspan="2" rowspan="1">
                  <ext-link xlink:href="https://genome.ucsc.edu/ENCODE/downloads.html" ext-link-type="uri">https://genome.ucsc.edu/ENCODE/downloads.html</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">GEO</td>
                <td align="left" colspan="2" rowspan="1">
                  <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">ENCODE Portal</td>
                <td align="left" colspan="2" rowspan="1">
                  <ext-link xlink:href="https://www.encodeproject.org/" ext-link-type="uri">https://www.encodeproject.org/</ext-link>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Roadmap</td>
                <td align="left" colspan="2" rowspan="1">
                  <ext-link xlink:href="https://egg2.wustl.edu/roadmap/web_portal/" ext-link-type="uri">https://egg2.wustl.edu/roadmap/web_portal/</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p>ChromHMM annotates the genome by assigning states for every 200bp interval. Consecutive states are merged by ChromHMM, and the size of these state assignments varies based on the number of times the same state is called in succession (i.e., multiples of 200). ChromHMM states were then relabeled to Promoter, Enhancer, Insulator, or Other, based on their emission probabilities and our annotations (e.g., <xref rid="pcbi.1009670.s008" ref-type="supplementary-material">S8 Fig</xref>). We overlapped these states with the ATAC-seq peaks that are of different lengths. To eliminate ambiguous annotations in our models, we only used ATAC-seq peaks that were unanimously (90% of its entirety) assigned to a single functional state among the 4 states: Promoter, Enhancer, Insulator, or Other. Filtering by 90% overlap with a single class label removed an average of 4002 peaks per sample, ranging from 0.3–16.2% of the total number of peaks per sample.</p>
    </sec>
    <sec id="sec017">
      <title>Comparison with alternative methods/assays</title>
      <p>We compared CoRE-ATAC to two sequence-based methods (DeepSEA [<xref rid="pcbi.1009670.ref022" ref-type="bibr">22</xref>] and LS-GKM [<xref rid="pcbi.1009670.ref032" ref-type="bibr">32</xref>]) and our previous neural network (NN) based method (PEAS [<xref rid="pcbi.1009670.ref020" ref-type="bibr">20</xref>]). For this comparison we focused on enhancer versus “other” predictions, the most difficult discrimination task in our models (<xref rid="pcbi.1009670.g002" ref-type="fig">Fig 2C</xref>), and compared all annotated regions from our ground truth test set (i.e., regions within chromosomes 3 and 11 for GM12878, K562, HSMM, and CD14<sup>+</sup> samples) (Tables <xref rid="pcbi.1009670.t001" ref-type="table">1</xref> and <xref rid="pcbi.1009670.t002" ref-type="table">2</xref>). The same training and testing set were used for CoRE-ATAC, PEAS, and LS-GKM. For DeepSEA, we used the web annotation tool (<ext-link xlink:href="https://hb.flatironinstitute.org/deepsea/" ext-link-type="uri">https://hb.flatironinstitute.org/deepsea/</ext-link>). DeepSEA makes multiple predictions of activity for a wide array histone marks and transcription factors (TFs) across multiple cell types. We therefore selected enhancer probabilities by taking the maximum probability score for H3K4me1 and H3K27ac across all cell types predicted by DeepSEA. For promoters, probability scores were selected using H3K4me3 and pol2. For insulators, probability scores were selected using CTCF. The area under the receiver operating characteristic curve (ROC AUC) and average precision metrics were used to compare the four methods (Figs <xref rid="pcbi.1009670.g002" ref-type="fig">2D</xref> and <xref rid="pcbi.1009670.s007" ref-type="supplementary-material">S7</xref>.).</p>
      <p>Naïve method comparisons focused on the 40 samples not used in model training to fairly assess CoRE-ATAC’s performance with respect to these methods. Multiple thresholds were applied for each Naïve method to identify the best threshold to set for predicting promoters, enhancers, and insulators. Promoters were tested using 1kb, 2kb, and 5kb distances to the nearest TSS, (distances calculated using HOMER [<xref rid="pcbi.1009670.ref033" ref-type="bibr">33</xref>]). Enhancers were tested using MACS2 [<xref rid="pcbi.1009670.ref051" ref-type="bibr">51</xref>] FDR qval of 0.01, 0.001, and 0.0001. Insulators were tested using the number of CTCF motifs greater than 0, 2, and 4. Promoters, enhancers, and insulators were selected using these thresholds, assigning probabilities 1.0 when the threshold requirement is met, and 0.0 otherwise. Finally, combined naïve approach performance was calculated selecting the best threshold (i.e., 2kb, 0.001, and 0 for promoter TSS, enhancer MACS2 qval, and insulator number of CTCF motifs respectively). Due to the nature of selecting enhancers using MACS2 qval, priority was given to promoters and then insulators. For the remaining regions that were not annotated as either promoter or insulator, enhancers and “other” were classified using MACS2 qval. Performances were evaluated using Matthews correlation coefficient.</p>
      <p>Alternative enhancer definitions were explored to understand how well CoRE-ATAC can predict active regulatory elements (i.e., promoter and enhancers) from FANTOM [<xref rid="pcbi.1009670.ref037" ref-type="bibr">37</xref>,<xref rid="pcbi.1009670.ref038" ref-type="bibr">38</xref>] and STARR-seq [<xref rid="pcbi.1009670.ref026" ref-type="bibr">26</xref>]. FANTOM enhancers identified using Cap Analysis of Gene Expression (CAGE) technology [<xref rid="pcbi.1009670.ref024" ref-type="bibr">24</xref>,<xref rid="pcbi.1009670.ref025" ref-type="bibr">25</xref>] were obtained for MCF7, A549, CD4<sup>+</sup> T cells, and PBMCs. We obtained STARR-seq active regulatory sites for A549 [<xref rid="pcbi.1009670.ref041" ref-type="bibr">41</xref>] from the Gene Expression Omnibus (GEO) [<xref rid="pcbi.1009670.ref068" ref-type="bibr">68</xref>,<xref rid="pcbi.1009670.ref069" ref-type="bibr">69</xref>] (GSE114063). These regions were then compared with CoRE-ATAC predictions, counting the number of predictions for each class within FANTOM5 enhancers and STARR-seq sites. Fisher’s exact test was used to calculate the significance of whether a peak was identified as an enhancer by CoRE-ATAC, FANTOM/STARR-seq, or both (i.e, using a 2x2 contingency table between CoRE-ATAC and FANTOM/STARR-seq enhancer annotations). All remaining non-enhancer ATAC-seq peaks were used as the background in these calculations.</p>
      <p>Massively Parallel Reporter Assay (MPRA) data were generated in MIN6 pancreatic beta cell line to study the regulatory activity of variants associated with Type-2-Diabetes [<xref rid="pcbi.1009670.ref042" ref-type="bibr">42</xref>]. Briefly, 4293 variants within islet ATAC-seq peaks were profiled for regulatory element activity using MPRA. Taking the union of islet peaks called across all 19 samples, we predicted <italic toggle="yes">cis</italic>-RE functions for each islet sample to obtain class probabilities for each region and islet sample. We then putatively identified <italic toggle="yes">cis</italic>-REs showing loss or gain of <italic toggle="yes">cis</italic>-RE activity using one-tailed point-biserial correlation p-values, identifying loci with probabilities that were significantly lower or higher between reference and alternative genotypes. The maximum absolute value correlation was obtained for each peak with genotype information by calculating the correlations for all comparisons among ref/ref, ref/alt, and alt/alt genotypes, using the sum of promoter and enhancer probabilities. Peaks with significant point-biserial correlation coefficients (p-value &lt; 0.01) were separated into two groups corresponding to the loss or gain of <italic toggle="yes">cis</italic>-RE activity (negative and positive correlations respectively) based on CoRE-ATAC predictions for different alleles. Finally, MPRA activity differences between alternative and reference alleles (log fold change in MPRA analyses) were compared with the activity differences inferred from CoRE-ATAC <italic toggle="yes">cis</italic>-RE class probabilities. Student t-test, and Mann Whitney U test were used to calculate the significanceofMPRA log foldchange values observed for predicted loss and gain of <italic toggle="yes">cis</italic>-RE activity both individuallyas well as comparatively.</p>
    </sec>
    <sec id="sec018">
      <title>snATAC seq data analyses and clustering</title>
      <p>Single nuclei ATAC-seq (snATAC) PBMC data [<xref rid="pcbi.1009670.ref013" ref-type="bibr">13</xref>] was obtained from GEO [<xref rid="pcbi.1009670.ref068" ref-type="bibr">68</xref>,<xref rid="pcbi.1009670.ref069" ref-type="bibr">69</xref>] (GSE129785). Sequence reads were processed using Cell Ranger ATAC and cells were clustered using our own implementation of a recently described snATAC clustering method [<xref rid="pcbi.1009670.ref013" ref-type="bibr">13</xref>], which uses two passes of clustering to identify cell type clusters. In the first pass, genomic regions were binned into 2500bp windows, counting the number of paired-end reads within each bin. The top 50,000 bins with the greatest number of reads were selected for clustering using Seurat [<xref rid="pcbi.1009670.ref070" ref-type="bibr">70</xref>,<xref rid="pcbi.1009670.ref071" ref-type="bibr">71</xref>], requiring a minimum of 185 cells per cluster. Peaks were called for each cluster independently using MACS2 (“-f BAMPE–nomodel,—keep-dup all”) and were used to perform a second pass of cell clustering as before, using peaks instead of bins, identifying a total of 15 clusters.</p>
      <p>Cell type annotations for these clusters were obtained by comparing snATAC profiles with ATAC-seq profiles of sorted immune cell types<italic toggle="yes">via</italic> flow cytometry. To identify marker peaks for each cell type, we selected 2–3 representative and high quality ATAC-seq samples per cell type [<xref rid="pcbi.1009670.ref014" ref-type="bibr">14</xref>,<xref rid="pcbi.1009670.ref017" ref-type="bibr">17</xref>] for 19 different immune cell types based on ATAC-seq library quality (FRIP score and read depth) and similarity between biological replicates (Spearman r). Marker peaks were identified from the signature profile generated by CIBERSORT [<xref rid="pcbi.1009670.ref072" ref-type="bibr">72</xref>], using its data pre-processing step. Hierarchical clustering was performed for read pileups within marker peaks for snATAC-seq clusters and sorted bulk data, which enabled annotating 15 clusters into 7 cell types. Cells that belong to the same cell type were pooled together and the functionality of <italic toggle="yes">cis</italic>-REs were predicted using CoRE-ATAC for 7 cell types by allowing duplicate reads. Predictions were evaluated using either ChromHMM annotations from Roadmap or in-house ChromHMM states (CD4<sup>+</sup> T and CD14<sup>+</sup> monocytes).</p>
      <p>Comparison of cell-specific enhancers were calculated using Fisher’s exact test. First, cell-specific ATAC-seq peaks were identified from union peaks by merging peaks called from all snATAC-seq clusters. Cell-specific peaks were identified by counting the number of overlapping peaks sets for each union peak. CoRE-ATAC and ChromHMM enhancers were identified from these cell-specific peaks, and Fisher’s exact test was applied to calculate the significance of CoRE-ATAC cell-specific enhancers overlapping with ChromHMM cell-specific enhancers. All remaining non-enhancer peaks were used as the background for these calculations.</p>
    </sec>
    <sec id="sec019">
      <title>SNP enrichments</title>
      <p>GWAS SNP enrichments were performed with GREGOR [<xref rid="pcbi.1009670.ref044" ref-type="bibr">44</xref>] software using index SNPs as well as linked SNPs (linkage disequilibrium threshold of R<sup>2</sup> 0.7 for the European (EUR) population). NHGRI-EBI GWAS Catalog SNPs [<xref rid="pcbi.1009670.ref073" ref-type="bibr">73</xref>] (Obtained January 8<sup>th</sup> 2020) for 3981 traits/diseases were used in enrichment analyses for different enhancer sets inferred by CoRE-ATAC.</p>
    </sec>
    <sec id="sec020">
      <title>Super enhancer analysis</title>
      <p>Super enhancer annotations were obtained for A549, MCF7, Islets, CD14<sup>+</sup>, CD4<sup>+</sup> T, CD8<sup>+</sup> T, monocyte-derived dendritic cells, NK, and B cells from SEdb [<xref rid="pcbi.1009670.ref043" ref-type="bibr">43</xref>]. We then calculated the percent of super enhancers found among CoRE-ATAC enhancer predictions to measure how well CoRE-ATAC predictions recapitulate these cell-type-specific enhancers.</p>
    </sec>
  </sec>
  <sec id="sec021" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pcbi.1009670.s001" position="float" content-type="local-data">
      <label>S1 Fig</label>
      <caption>
        <title>ChromHMM emission probability clusters reveal 10 consistent chromatin states.</title>
        <p>We clustered the ChromHMM emission probabilities using Pearson’s correlation coefficient to identify 10 chromatin states that were consistently present among all 10 cell types for which we recalled ChromHMM states. These 10 functional states include, insulators, repressed, low signal, enhancer, active enhancers, active promoter, flanking enhancer, promoter, genic enhancer, and transcribed regions. Numbers preceding the cell types are the emission states corresponding to <xref rid="pcbi.1009670.s008" ref-type="supplementary-material">S8 Fig</xref>. Note that genic enhancers are shown by two groups which correspond to active genic enhancers and genic enhancers which we combined due to the low number of cell types included within these clusters independently. Also note that for insulators, we selected islet state 7 as this was the state with the strongest CTCF signal (<xref rid="pcbi.1009670.s008" ref-type="supplementary-material">S8 Fig</xref>), maintaining one insulator state per cell type.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s001.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s002" position="float" content-type="local-data">
      <label>S2 Fig</label>
      <caption>
        <title>CoRE-ATAC 10 State model ground truth selection.</title>
        <p>To select a ground truth for predicting the 10 functional states we identified, we corroborated our ChromHMM state calls with Roadmap 18 state models. (Top) Highlighted concordant recalled ChromHMM states with corresponding Roadmaps states to select active promoters (red), promoters (pink), flanking enhancers (orange), active enhancers (orange yellow), enhancers (yellow), genic enhancers (greenish yellow), transcribed (dark green), insulator (blue), repressed (dark gray), and low signal (light gray) functional states. (Bottom) The number of ground truth examples for each cell type used in model training and functional state examples selected. Note: Roadmap 18-state models do not include insulator states and we therefore chose insulators from our ChromHMM models that included CTCF ChIP-seq data. These predicted insulators mostly overlap with the Quiescent state in the 18-state models, suggesting that this ChromHMM state (Quies) is a miscellaneous functional state in the absence of CTCF ChIP-seq.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s002.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s003" position="float" content-type="local-data">
      <label>S3 Fig</label>
      <caption>
        <title>CoRE-ATAC 10 State performances.</title>
        <p>(<bold>A</bold>) Confusion matrices of combined CoRE-ATAC performances for 10 state models. (<bold>B</bold>) Confusion matrices of CoRE-ATAC performance for 10 state models in GM12878. CoRE-ATAC 10-state models. Only 4 of the 10 chromatin states were predicted by CoRE-ATAC. Smaller subsets of these four functional states (i.e., promoters, enhancers, insulators and other) were predicted as the state with the highest number of examples.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s003.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s004" position="float" content-type="local-data">
      <label>S4 Fig</label>
      <caption>
        <title>CoRE-ATAC 4 State model ground truth selection.</title>
        <p>(Top) Highlighted concordant recalled ChromHMM states with corresponding Roadmaps states to select promoters, enhancers, insulators and other. (Bottom) The number of ground truth examples for each cell type used in model training and functional state examples selected. Flanking enhancers were excluded as these regions are ambiguous and could be annotated as promoters. Merging states and relaxing concordance with Roadmap allowed for selecting more examples for model training. Note: Roadmap 18-state models do not include insulator states and we therefore chose insulators from our ChromHMM models that included CTCF ChIP-seq data. These predicted insulators mostly overlap with the Quiescent state in the 18-state models, suggesting that this ChromHMM state (Quies) is a miscellaneous functional state in the absence of CTCF ChIP-seq.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s004.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s005" position="float" content-type="local-data">
      <label>S5 Fig</label>
      <caption>
        <title>CoRE-ATAC predicts all functional annotations with high precision.</title>
        <p>Precision recall curves of held out test data for each sample used in model training. Individual class performances reveal that CoRE-ATAC predicts all classes with high average precision.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s005.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s006" position="float" content-type="local-data">
      <label>S6 Fig</label>
      <caption>
        <title>Majority of “Other” peaks are low signal.</title>
        <p>(Left) The number of peaks identified as Transcribed, Repressed, or Low Signal by ChromHMM states (blue), overlayed with the number of these peaks predicted as “Other” by CoRE-ATAC. (Right) The fraction of Transcribed, Repressed or Low Signal states annotated as “Other” by CoRE-ATAC. The majority of these states (&gt;50% for each state, &gt;69% overall) are predicted as “Other”.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s006.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s007" position="float" content-type="local-data">
      <label>S7 Fig</label>
      <caption>
        <title>CoRE-ATAC component comparisons with sequence-based enhancer predictions.</title>
        <p>Receiver operating characteristic (ROC) curves (<bold>A</bold>) and Precision Recall curves (<bold>B</bold>) for different enhancer prediction models: CoRE-ATAC components, PEAS, DeepSEA and LS-GKM. Models were evaluated for predicting enhancer versus “other” classes for chr3 and chr11 of the GM12878, HSMM, K562, and CD14+ datasets. Sequence based approaches had similar performances, including CoRE-ATAC’s sequence-based component. The ATAC-seq signal based (CoRE-ATAC-Signal) component of CoRE-ATAC alone outperforms all sequence-based approaches, however combining both sequence and signal greatly enhances predictive performances. PEAS captures more information than signal alone, however, is still underperforming compared to CoRE-ATAC-Sig+Seq model. Finally, the CoRE-ATAC model, which includes PEAS features, showed a slight improvement over the CoRE-ATAC-Sig+Seq model, likely taking advantage of the known features such as number of known motifs and conservation scores used in PEAS. (<bold>c</bold>) ROC AUC and (<bold>d</bold>) average precision scores for predicting promoters in chr3 and chr11. All models perform with high ROC AUC and Average Precision for predicting promoters due to distinct signatures for both sequence and ATAC-eq signal. (<bold>e</bold>) ROC AUC and (<bold>f</bold>) average precision scores for predicting insulators in chr3 and chr11. DNA sequence is the approaches are the best performing models for predicting CTCF insulators, while ATAC-seq signal alone provides the weakest predictive power for annotating these <italic toggle="yes">cis</italic>-REs.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s007.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s008" position="float" content-type="local-data">
      <label>S8 Fig</label>
      <caption>
        <title>ChromHMM emission probabilities for all cell types.</title>
        <p>Recalled ChromHMM states for 10 of the 11 cell types used in this study. Each chromHMM run included enhancer marker H3k4me1, promoter marker H3k4me3, repressor marker H3k27me3, active <italic toggle="yes">cis</italic>-RE marker H3k27ac, transcribed marker H3k36me3, heterochromatin marker H3k9me3, and CTCF insulator marker CTCF (when available). Emission probabilities revealed consistent histone modification mark combinations present throughout these diverse cell types. Color annotations next to each heatmap of ChromHMM states represent the inferred ChromHMM state and the final 4 state relabeling.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s008.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s009" position="float" content-type="local-data">
      <label>S9 Fig</label>
      <caption>
        <title>CoRE-ATAC Islet insulator predictions.</title>
        <p>(<bold>A</bold>) Cross cell type model performances when including islet insulators. Using poor quality CTCF ChIP-seq data (as evident from <xref rid="pcbi.1009670.s008" ref-type="supplementary-material">S8 Fig</xref>) as a ground truth resulted in reduced model performances for all islet samples. (<bold>B</bold>) De novo motif enrichment for CoRE-ATAC insulator predictions in islets. Predicted insulators are highly enriched for CTCF with 76.1% of regions harboring a CTCF motif. Incorporating both DNA sequence and ATAC-seq signal enables CoRE-ATAC to detect a majority of insulators using the CTCF motif while detecting other insulators <italic toggle="yes">via</italic> other features learned in model training.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s009.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s010" position="float" content-type="local-data">
      <label>S10 Fig</label>
      <caption>
        <title>CTCF enrichment of CoRE-ATAC insulator predictions.</title>
        <p>Overlap of CTCF ChIP-seq peaks with CoRE-ATAC insulator and non-insulator predictions. Majority of CoRE-ATAC insulator predictions overlapped with CTCF ChIP-seq peaks. Note: Overlaps between insulator and non-insulators are the result of CTCF peaks bridging the gap between these genomic regions when merging peaks for the union.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s010.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s011" position="float" content-type="local-data">
      <label>S11 Fig</label>
      <caption>
        <title>CoRE-ATAC outperforms threshold-based naïve/baseline annotations.</title>
        <p>CoRE-ATAC outperforms each threshold-based method for detecting promoters, enhancers, insulators, and combined annotations. Matthews Correlation Coefficient was used to measure performances as it accounts for true positives, true negatives, false positives, and false negatives simultaneously within its function and is an ideal measurement for performances when probabilities are static as in the case with all threshold-based approaches (i.e., probability = 1.0 if satisfying the threshold, 0.0 otherwise). CoRE-ATAC consistently had the best performance compared to each baseline. For detecting promoters, the best threshold was identified as ATAC-seq peaks within 2kb of the promoter, for enhancers, an FDR qval score is less than 0.0001, and for insulators, whether or not the region contained a single (n = 1) CTCF motif was the best performing threshold. Finally, combining all three of these thresholds confirmed that CoRE-ATAC improves our ability to predict <italic toggle="yes">cis</italic>-RE function, outperforming commonly used methods for detecting promoters, enhancers, and insulators.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s011.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s012" position="float" content-type="local-data">
      <label>S12 Fig</label>
      <caption>
        <title>Performance of alternative methods on cell types that are not used in training.</title>
        <p>(<bold>A</bold>) ROC AUC, (<bold>B</bold>) average precision, (<bold>C</bold>) F1, and (<bold>D</bold>) recall scores for predicting enhancers in chr3 and chr11 across different cell types not used in model training. CoRE-ATAC generalizes well for predicting enhancers in new cell types. CoRE-ATAC outperforms alternative sequence-based models (Mann Whitney P-Values over ROC AUC &lt; 0.0096). Note: The model for DeepSEA was trained using MCF7, A549, Stomach, Heart Left Ventricle, Heart Right Atrium, Pancreas, Liver, HEPG2, CD8 Naïve T Cells, and CD4+ T cells.(<bold>E</bold>-<bold>H</bold>) Performance scores for predicting promoters in chr3 and chr11 across different cell types not used in model training. All models predict promoters with high accuracy, irrespective of cell type. (<bold>I</bold>-<bold>L</bold>) Performance scores for predicting insulators in chr3 and chr11 across different cell types not used in model training. DeepSEA outperforms other methods for detecting CTCF insulators. CTCF has a well characterized DNA binding sequence that is very predictive.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s012.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s013" position="float" content-type="local-data">
      <label>S13 Fig</label>
      <caption>
        <title>CoRE-ATAC performance with different number of cell types used in training.</title>
        <p>Three CoRE-ATAC models were trained using: 1) 7 different cell types: GM12878, HSMM, Pancreas, Stomach, Thyroid, Testis, and Transverse Colon, 2) 9 different cell types: 7 cell type model with 2 Heart samples (Left Ventricle and Right Atrium Auricular Region) and 3) 11 different cell types: 9 cell type model with Liver and HepG2 samples. CoRE-ATAC performances did not significantly improve with increased number of cell types used for training for promoter, enhancer, or other prediction. Insulator prediction showed significant differences between models (Mann Whitney P-Values &lt; 1.91e-06, Average Precision), however, the effect of these differences suggests that the model decreased in performance as more data was used for model training.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s013.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s014" position="float" content-type="local-data">
      <label>S14 Fig</label>
      <caption>
        <title>CoRE-ATAC predicted enhancers significantly overlap FANTOM and STARR-seq enhancers.</title>
        <p>(<bold>A</bold>) Distribution of CoRE-ATAC predictions for FANTOM enhancers in test chromosomes (chr3 and chr11). (<bold>B</bold>) Distribution of CoRE-ATAC predictions for test chromosomes. Pairs of bars represent comparisons between ChromHMM (H) and CoRE-ATAC (C), where each pair represents a sample/replicate for the respective cell type. (<bold>C</bold>,<bold>D</bold>) Histogram of distances to the nearest TSS for STARR-seq enhancers predicted as promoters by CoRE-ATAC for all chromosomes (<bold>C</bold>) and test chromosomes (<bold>D</bold>). Majority of predicted promoters are within 1kb of a TSS. (<bold>e</bold>,<bold>f</bold>) Histogram of distances to the nearest TSS for STARR-seq enhancers predicted as enhancers by CoRE-ATAC for all chromosomes (<bold>E</bold>) and test chromosomes (<bold>F</bold>). Majority of predicted enhancers are distal (&gt; = 20kb) from the nearest TSS. STARR-seq enhancers annotated as promoters result from the close proximity these enhancers are to a TSS. (<bold>G</bold>,<bold>H</bold>) ChromHMM annotation (relabeled to 10 classes) distribution for STARR-seq enhancers in A549 for all chromosomes (<bold>G</bold>) and test chromosomes (<bold>H</bold>). Majority of STARR-seq enhancers are annotated as promoter or enhancer by ChromHMM.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s014.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s015" position="float" content-type="local-data">
      <label>S15 Fig</label>
      <caption>
        <title>CoRE-ATAC predicts direction of effect for loci not observed in model training.</title>
        <p>MIN6 MPRA log fold change values for genomic regions predicted as losing or gaining cis-RE function based on CoRE-ATAC probabilities for reference and alternative alleles in test chromosomes (chr3 and chr11). Significance for predicted loss and predicted gain categories was calculated using student’s t-test for MPRA log fold change values being less than or greater than 0 respectively. Significance comparing the predicted loss and predicted gain of MPRA fold change distributions was calculated using Mann-Whitney U test. Concordant direction of effect (P-Value &lt; 0.022) was observed for both for CoRE-ATAC predictions and MPRA activity levels for chromosomes not used in model training.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s015.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s016" position="float" content-type="local-data">
      <label>S16 Fig</label>
      <caption>
        <title>CoRE-ATAC predicts <italic toggle="yes">cis</italic>-REs in snATAC-seq cell type clusters.</title>
        <p>Average precision, ROC AUC, F1 score, and recall for predicting cis-RE function in snATAC for 6 annotated clusters with available ChromHMM states. Model performances suggest that CoRE-ATAC is an effective tool for interrogating cis-RE activity from snATAC data.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s016.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s017" position="float" content-type="local-data">
      <label>S17 Fig</label>
      <caption>
        <title>Predicted insulators in snATAC data are enriched for CTCF.</title>
        <p>Top de novo motif enrichments for all seven cell type clusters for snATAC data. Insulator predictions for all cell types are significantly enriched for motifs with high similarity with CTCF.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s017.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s018" position="float" content-type="local-data">
      <label>S18 Fig</label>
      <caption>
        <title>CoRE-ATAC predictions identify cell specific enhancers in snATAC-seq data.</title>
        <p>Number of enhancers identified for the top 25 cell types and combinations by the number of enhancers predicted by CoRE-ATAC.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s018.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s019" position="float" content-type="local-data">
      <label>S19 Fig</label>
      <caption>
        <title>Comparison of CoRE-ATAC and ChromHMM cell-specific enhancers.</title>
        <p>Overlap of CoRE-ATAC andChromHMM cell-specific enhancers. CoRE-ATAC predictions significantly overlap ChromHMM enhancers for all cell types (P-Values &lt; 3.85e-190 Fisher exact test). Overlaps were less significant for T cell comparisons, partially due to the differences in sorted cells used in ChromHMM annotations and total cells used in CoRE-ATAC predictions from snATAC-seq data.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s019.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s020" position="float" content-type="local-data">
      <label>S20 Fig</label>
      <caption>
        <title>GREGOR SNP Enrichments for CoRE-ATAC predictions.</title>
        <p>Selected disease SNP enrichments for (<bold>A</bold>) promoters, (<bold>B</bold>) insulators, (<bold>C</bold>) other predicted annotations, and (<bold>d</bold>) all ATAC-seq peaks. Enhancers are more enriched for relevant diseases as expected (<xref rid="pcbi.1009670.g005" ref-type="fig">Fig 5E</xref>) and contribute the most to disease SNP enrichments.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s020.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1009670.s021" position="float" content-type="local-data">
      <label>S21 Fig</label>
      <caption>
        <title>Runtime performance comparison for classifying <italic toggle="yes">cis</italic>-REs with CoRE-ATAC using CPU and GPU hardware.</title>
        <p>We measured the time (in seconds) to classify cis-REs using either an intel Core i9 CPU or a Tesla V100 GPU. Comparisons revealed a linear time increase as the number of peaks increases. Predictions with the CPU take ~2 minutes for 75000 peaks, which is reasonable for users of CoRE-ATAC. GPU based method comparatively take less than 20 seconds, showing the power of using a GPU for such analyses.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pcbi.1009670.s021.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>We thank members of the Ucar, Stitzel, Beck, and Lee labs at JAX-GM for their insightful feedback throughout this project.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="pcbi.1009670.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Hindorff</surname><given-names>LA</given-names></name>, <name><surname>Sethupathy</surname><given-names>P</given-names></name>, <name><surname>Junkins</surname><given-names>HA</given-names></name>, <name><surname>Ramos</surname><given-names>EM</given-names></name>, <name><surname>Mehta</surname><given-names>JP</given-names></name>, <name><surname>Collins</surname><given-names>FS</given-names></name>, <etal>et al</etal>. <article-title>Potential etiologic and functional implications of genome-wide association loci for human diseases and traits</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2009</year><month>Jun</month><day>9</day>;<volume>106</volume>(<issue>23</issue>):<fpage>9362</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.0903103106</pub-id><?supplied-pmid 19474294?><pub-id pub-id-type="pmid">19474294</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Hnisz</surname><given-names>D</given-names></name>, <name><surname>Abraham</surname><given-names>BJ</given-names></name>, <name><surname>Lee</surname><given-names>TI</given-names></name>, <name><surname>Lau</surname><given-names>A</given-names></name>, <name><surname>Saint-André</surname><given-names>V</given-names></name>, <name><surname>Sigova</surname><given-names>AA</given-names></name>, <etal>et al</etal>. <article-title>Super-Enhancers in the Control of Cell Identity and Disease</article-title>. <source>Cell</source>. <year>2013</year><month>Nov</month>;<volume>155</volume>(<issue>4</issue>):<fpage>934</fpage>–<lpage>47</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2013.09.053</pub-id><?supplied-pmid 24119843?><pub-id pub-id-type="pmid">24119843</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Parker</surname><given-names>SCJ</given-names></name>, <name><surname>Stitzel</surname><given-names>ML</given-names></name>, <name><surname>Taylor</surname><given-names>DL</given-names></name>, <name><surname>Orozco</surname><given-names>JM</given-names></name>, <name><surname>Erdos</surname><given-names>MR</given-names></name>, <name><surname>Akiyama</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2013</year><month>Oct</month><day>29</day>;<volume>110</volume>(<issue>44</issue>):<fpage>17921</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1317023110</pub-id><?supplied-pmid 24127591?><pub-id pub-id-type="pmid">24127591</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Gaffney</surname><given-names>DJ</given-names></name>, <name><surname>McVicker</surname><given-names>G</given-names></name>, <name><surname>Pai</surname><given-names>AA</given-names></name>, <name><surname>Fondufe-Mittendorf</surname><given-names>YN</given-names></name>, <name><surname>Lewellen</surname><given-names>N</given-names></name>, <name><surname>Michelini</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Controls of Nucleosome Positioning in the Human Genome</article-title>. <source>PLoS Genet</source>. <year>2012</year><month>Nov</month><day>15</day>;<volume>8</volume>(<issue>11</issue>):<fpage>e1003036</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1003036</pub-id><?supplied-pmid 23166509?><pub-id pub-id-type="pmid">23166509</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Kumasaka</surname><given-names>N</given-names></name>, <name><surname>Knights</surname><given-names>AJ</given-names></name>, <name><surname>Gaffney</surname><given-names>DJ</given-names></name>. <article-title>Fine-mapping cellular QTLs with RASQUAL and ATAC-seq</article-title>. <source>Nat Genet</source>. <year>2016</year><month>Feb</month>;<volume>48</volume>(<issue>2</issue>):<fpage>206</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3467</pub-id><?supplied-pmid 26656845?><pub-id pub-id-type="pmid">26656845</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Alasoo</surname><given-names>K</given-names></name>, <name><surname>Rodrigues</surname><given-names>J</given-names></name>, <name><surname>Mukhopadhyay</surname><given-names>S</given-names></name>, <name><surname>Knights</surname><given-names>AJ</given-names></name>, <name><surname>Mann</surname><given-names>AL</given-names></name>, <name><surname>Kundu</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response</article-title>. <source>Nat Genet</source>. <year>2018</year><month>Mar</month>;<volume>50</volume>(<issue>3</issue>):<fpage>424</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-018-0046-7</pub-id><?supplied-pmid 29379200?><pub-id pub-id-type="pmid">29379200</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Khetan</surname><given-names>S</given-names></name>, <name><surname>Kursawe</surname><given-names>R</given-names></name>, <name><surname>Youn</surname><given-names>A</given-names></name>, <name><surname>Lawlor</surname><given-names>N</given-names></name>, <name><surname>Jillette</surname><given-names>A</given-names></name>, <name><surname>Marquez</surname><given-names>EJ</given-names></name>, <etal>et al</etal>. <article-title>Type 2 Diabetes–Associated Genetic Variants Regulate Chromatin Accessibility in Human Islets</article-title>. <source>Diabetes</source>. <year>2018</year><month>Nov</month>;<volume>67</volume>(<issue>11</issue>):<fpage>2466</fpage>–<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/db18-0393</pub-id><?supplied-pmid 30181159?><pub-id pub-id-type="pmid">30181159</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><collab>ENCODE Project Consortium</collab>. <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>. <source>Nature</source>. <year>2012</year><month>Sep</month><day>6</day>;<volume>489</volume>(<issue>7414</issue>):<fpage>57</fpage>–<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><?supplied-pmid 22955616?><pub-id pub-id-type="pmid">22955616</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><collab>Roadmap Epigenomics Consortium</collab>, <name><surname>Kundaje</surname><given-names>A</given-names></name>, <name><surname>Meuleman</surname><given-names>W</given-names></name>, <name><surname>Ernst</surname><given-names>J</given-names></name>, <name><surname>Bilenky</surname><given-names>M</given-names></name>, <name><surname>Yen</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Integrative analysis of 111 reference human epigenomes</article-title>. <source>Nature</source>. <year>2015</year><month>Feb</month><day>19</day>;<volume>518</volume>(<issue>7539</issue>):<fpage>317</fpage>–<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature14248</pub-id><?supplied-pmid 25693563?><pub-id pub-id-type="pmid">25693563</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Ernst</surname><given-names>J</given-names></name>, <name><surname>Kellis</surname><given-names>M</given-names></name>. <article-title>ChromHMM: automating chromatin-state discovery and characterization</article-title>. <source>Nat Methods</source>. <year>2012</year><month>Mar</month>;<volume>9</volume>(<issue>3</issue>):<fpage>215</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.1906</pub-id><?supplied-pmid 22373907?><pub-id pub-id-type="pmid">22373907</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Buenrostro</surname><given-names>JD</given-names></name>, <name><surname>Giresi</surname><given-names>PG</given-names></name>, <name><surname>Zaba</surname><given-names>LC</given-names></name>, <name><surname>Chang</surname><given-names>HY</given-names></name>, <name><surname>Greenleaf</surname><given-names>WJ</given-names></name>. <article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title>. <source>Nat Methods</source>. <year>2013</year><month>Dec</month>;<volume>10</volume>(<issue>12</issue>):<fpage>1213</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id><?supplied-pmid 24097267?><pub-id pub-id-type="pmid">24097267</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Buenrostro</surname><given-names>JD</given-names></name>, <name><surname>Wu</surname><given-names>B</given-names></name>, <name><surname>Chang</surname><given-names>HY</given-names></name>, <name><surname>Greenleaf</surname><given-names>WJ</given-names></name>. <article-title>ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide</article-title>. <source>Current Protocols in Molecular Biology</source> [Internet]. <year>2015</year>
<month>Jan</month> [cited 2021 Aug 18];<volume>109</volume>(<issue>1</issue>). Available from: <ext-link xlink:href="https://onlinelibrary.wiley.com/doi/10.1002/0471142727.mb2129s109" ext-link-type="uri">https://onlinelibrary.wiley.com/doi/10.1002/0471142727.mb2129s109</ext-link>
<?supplied-pmid 25559105?><pub-id pub-id-type="pmid">25559105</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Satpathy</surname><given-names>AT</given-names></name>, <name><surname>Granja</surname><given-names>JM</given-names></name>, <name><surname>Yost</surname><given-names>KE</given-names></name>, <name><surname>Qi</surname><given-names>Y</given-names></name>, <name><surname>Meschi</surname><given-names>F</given-names></name>, <name><surname>McDermott</surname><given-names>GP</given-names></name>, <etal>et al</etal>. <article-title>Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion</article-title>. <source>Nat Biotechnol</source>. <year>2019</year>;<volume>37</volume>(<issue>8</issue>):<fpage>925</fpage>–<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41587-019-0206-z</pub-id><?supplied-pmid 31375813?><pub-id pub-id-type="pmid">31375813</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Ucar</surname><given-names>D</given-names></name>, <name><surname>Márquez</surname><given-names>EJ</given-names></name>, <name><surname>Chung</surname><given-names>C-H</given-names></name>, <name><surname>Marches</surname><given-names>R</given-names></name>, <name><surname>Rossi</surname><given-names>RJ</given-names></name>, <name><surname>Uyar</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The chromatin accessibility signature of human immune aging stems from CD8+ T cells</article-title>. <source>Journal of Experimental Medicine</source>. <year>2017</year><month>Oct</month><day>2</day>;<volume>214</volume>(<issue>10</issue>):<fpage>3123</fpage>–<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1084/jem.20170416</pub-id><?supplied-pmid 28904110?><pub-id pub-id-type="pmid">28904110</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Pliner</surname><given-names>HA</given-names></name>, <name><surname>Packer</surname><given-names>JS</given-names></name>, <name><surname>McFaline-Figueroa</surname><given-names>JL</given-names></name>, <name><surname>Cusanovich</surname><given-names>DA</given-names></name>, <name><surname>Daza</surname><given-names>RM</given-names></name>, <name><surname>Aghamirzaie</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data</article-title>. <source>Molecular Cell</source>. <year>2018</year><month>Sep</month>;<volume>71</volume>(<issue>5</issue>):<fpage>858</fpage>–<lpage>871.e8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.044</pub-id><?supplied-pmid 30078726?><pub-id pub-id-type="pmid">30078726</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Cho</surname><given-names>SW</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Sun</surname><given-names>R</given-names></name>, <name><surname>Mumbach</surname><given-names>MR</given-names></name>, <name><surname>Carter</surname><given-names>AC</given-names></name>, <name><surname>Chen</surname><given-names>YG</given-names></name>, <etal>et al</etal>. <article-title>Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element</article-title>. <source>Cell</source>. <year>2018</year><month>May</month>;<volume>173</volume>(<issue>6</issue>):<fpage>1398</fpage>–<lpage>1412.e22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.068</pub-id><?supplied-pmid 29731168?><pub-id pub-id-type="pmid">29731168</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Calderon</surname><given-names>D</given-names></name>, <name><surname>Nguyen</surname><given-names>MLT</given-names></name>, <name><surname>Mezger</surname><given-names>A</given-names></name>, <name><surname>Kathiria</surname><given-names>A</given-names></name>, <name><surname>Müller</surname><given-names>F</given-names></name>, <name><surname>Nguyen</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Landscape of stimulation-responsive chromatin across diverse human immune cells</article-title>. <source>Nat Genet</source>. <year>2019</year><month>Oct</month>;<volume>51</volume>(<issue>10</issue>):<fpage>1494</fpage>–<lpage>505</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-019-0505-9</pub-id><?supplied-pmid 31570894?><pub-id pub-id-type="pmid">31570894</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Lawlor</surname><given-names>N</given-names></name>, <name><surname>Márquez</surname><given-names>EJ</given-names></name>, <name><surname>Orchard</surname><given-names>P</given-names></name>, <name><surname>Narisu</surname><given-names>N</given-names></name>, <name><surname>Shamim</surname><given-names>MS</given-names></name>, <name><surname>Thibodeau</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Multiomic Profiling Identifies cis-Regulatory Networks Underlying Human Pancreatic β Cell Identity and Function</article-title>. <source>Cell Reports</source>. <year>2019</year><month>Jan</month>;<volume>26</volume>(<issue>3</issue>):<fpage>788</fpage>–<lpage>801.e6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.083</pub-id><?supplied-pmid 30650367?><pub-id pub-id-type="pmid">30650367</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Chu</surname><given-names>T</given-names></name>, <name><surname>Choate</surname><given-names>LA</given-names></name>, <name><surname>Danko</surname><given-names>CG</given-names></name>. <article-title>Identification of regulatory elements from nascent transcription using dREG</article-title>. <source>Genome Res</source>. <year>2019</year><month>Feb</month>;<volume>29</volume>(<issue>2</issue>):<fpage>293</fpage>–<lpage>303</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.238279.118</pub-id><?supplied-pmid 30573452?><pub-id pub-id-type="pmid">30573452</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Thibodeau</surname><given-names>A</given-names></name>, <name><surname>Uyar</surname><given-names>A</given-names></name>, <name><surname>Khetan</surname><given-names>S</given-names></name>, <name><surname>Stitzel</surname><given-names>ML</given-names></name>, <name><surname>Ucar</surname><given-names>D</given-names></name>. <article-title>A neural network based model effectively predicts enhancers from clinical ATAC-seq samples</article-title>. <source>Sci Rep</source>. <year>2018</year><month>Dec</month>;<volume>8</volume>(<issue>1</issue>):<fpage>16048</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-34420-9</pub-id><?supplied-pmid 30375457?><pub-id pub-id-type="pmid">30375457</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Kelley</surname><given-names>DR</given-names></name>, <name><surname>Snoek</surname><given-names>J</given-names></name>, <name><surname>Rinn</surname><given-names>JL</given-names></name>. <article-title>Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks</article-title>. <source>Genome Res</source>. <year>2016</year><month>Jul</month>;<volume>26</volume>(<issue>7</issue>):<fpage>990</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.200535.115</pub-id><?supplied-pmid 27197224?><pub-id pub-id-type="pmid">27197224</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>J</given-names></name>, <name><surname>Troyanskaya</surname><given-names>OG</given-names></name>. <article-title>Predicting effects of noncoding variants with deep learning–based sequence model</article-title>. <source>Nat Methods</source>. <year>2015</year><month>Oct</month>;<volume>12</volume>(<issue>10</issue>):<fpage>931</fpage>–<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.3547</pub-id><?supplied-pmid 26301843?><pub-id pub-id-type="pmid">26301843</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>B</given-names></name>, <name><surname>Liu</surname><given-names>F</given-names></name>, <name><surname>Ren</surname><given-names>C</given-names></name>, <name><surname>Ouyang</surname><given-names>Z</given-names></name>, <name><surname>Xie</surname><given-names>Z</given-names></name>, <name><surname>Bo</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>BiRen: predicting enhancers with a deep-learning-based model using the DNA sequence alone</article-title>. <source>Bioinformatics</source>. <year>2017</year><month>Jul</month><day>1</day>;<volume>33</volume>(<issue>13</issue>):<fpage>1930</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btx105</pub-id><?supplied-pmid 28334114?><pub-id pub-id-type="pmid">28334114</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Kodzius</surname><given-names>R</given-names></name>, <name><surname>Kojima</surname><given-names>M</given-names></name>, <name><surname>Nishiyori</surname><given-names>H</given-names></name>, <name><surname>Nakamura</surname><given-names>M</given-names></name>, <name><surname>Fukuda</surname><given-names>S</given-names></name>, <name><surname>Tagami</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>CAGE: cap analysis of gene expression.</article-title><source>Nat Methods</source>. <year>2006</year><month>Mar</month>;<volume>3</volume>(<issue>3</issue>):<fpage>211</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth0306-211</pub-id><?supplied-pmid 16489339?><pub-id pub-id-type="pmid">16489339</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>de Hoon</surname><given-names>M</given-names></name>, <name><surname>Shin</surname><given-names>JW</given-names></name>, <name><surname>Carninci</surname><given-names>P</given-names></name>. <article-title>Paradigm shifts in genomics through the FANTOM projects</article-title>. <source>Mamm Genome</source>. <year>2015</year><month>Oct</month>;<volume>26</volume>(<issue>9–10</issue>):<fpage>391</fpage>–<lpage>402</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00335-015-9593-8</pub-id><?supplied-pmid 26253466?><pub-id pub-id-type="pmid">26253466</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Arnold</surname><given-names>CD</given-names></name>, <name><surname>Gerlach</surname><given-names>D</given-names></name>, <name><surname>Stelzer</surname><given-names>C</given-names></name>, <name><surname>Boryn</surname><given-names>LM</given-names></name>, <name><surname>Rath</surname><given-names>M</given-names></name>, <name><surname>Stark</surname><given-names>A</given-names></name>. <article-title>Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq</article-title>. <source>Science</source>. <year>2013</year><month>Mar</month><day>1</day>;<volume>339</volume>(<issue>6123</issue>):<fpage>1074</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1232542</pub-id><?supplied-pmid 23328393?><pub-id pub-id-type="pmid">23328393</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Melnikov</surname><given-names>A</given-names></name>, <name><surname>Murugan</surname><given-names>A</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Tesileanu</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Rogov</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay</article-title>. <source>Nat Biotechnol</source>. <year>2012</year><month>Mar</month>;<volume>30</volume>(<issue>3</issue>):<fpage>271</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nbt.2137</pub-id><?supplied-pmid 22371084?><pub-id pub-id-type="pmid">22371084</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Whyte</surname><given-names>WA</given-names></name>, <name><surname>Orlando</surname><given-names>DA</given-names></name>, <name><surname>Hnisz</surname><given-names>D</given-names></name>, <name><surname>Abraham</surname><given-names>BJ</given-names></name>, <name><surname>Lin</surname><given-names>CY</given-names></name>, <name><surname>Kagey</surname><given-names>MH</given-names></name>, <etal>et al</etal>. <article-title>Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes</article-title>. <source>Cell</source>. <year>2013</year><month>Apr</month>;<volume>153</volume>(<issue>2</issue>):<fpage>307</fpage>–<lpage>19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.035</pub-id><?supplied-pmid 23582322?><pub-id pub-id-type="pmid">23582322</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Ong</surname><given-names>C-T</given-names></name>, <name><surname>Corces</surname><given-names>VG</given-names></name>. <article-title>CTCF: an architectural protein bridging genome topology and function</article-title>. <source>Nat Rev Genet</source>. <year>2014</year><month>Apr</month>;<volume>15</volume>(<issue>4</issue>):<fpage>234</fpage>–<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrg3663</pub-id><?supplied-pmid 24614316?><pub-id pub-id-type="pmid">24614316</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Heintzman</surname><given-names>ND</given-names></name>, <name><surname>Stuart</surname><given-names>RK</given-names></name>, <name><surname>Hon</surname><given-names>G</given-names></name>, <name><surname>Fu</surname><given-names>Y</given-names></name>, <name><surname>Ching</surname><given-names>CW</given-names></name>, <name><surname>Hawkins</surname><given-names>RD</given-names></name>, <etal>et al</etal>. <article-title>Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome</article-title>. <source>Nat Genet</source>. <year>2007</year><month>Mar</month>;<volume>39</volume>(<issue>3</issue>):<fpage>311</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng1966</pub-id><?supplied-pmid 17277777?><pub-id pub-id-type="pmid">17277777</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Visel</surname><given-names>A</given-names></name>, <name><surname>Blow</surname><given-names>MJ</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Akiyama</surname><given-names>JA</given-names></name>, <name><surname>Holt</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>ChIP-seq accurately predicts tissue-specific activity of enhancers</article-title>. <source>Nature</source>. <year>2009</year><month>Feb</month>;<volume>457</volume>(<issue>7231</issue>):<fpage>854</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature07730</pub-id><?supplied-pmid 19212405?><pub-id pub-id-type="pmid">19212405</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>D.</given-names></name><article-title>LS-GKM: a new gkm-SVM for large-scale datasets</article-title>. <source>Bioinformatics</source>. <year>2016</year><month>Jul</month><day>15</day>;<volume>32</volume>(<issue>14</issue>):<fpage>2196</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btw142</pub-id><?supplied-pmid 27153584?><pub-id pub-id-type="pmid">27153584</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Heinz</surname><given-names>S</given-names></name>, <name><surname>Benner</surname><given-names>C</given-names></name>, <name><surname>Spann</surname><given-names>N</given-names></name>, <name><surname>Bertolino</surname><given-names>E</given-names></name>, <name><surname>Lin</surname><given-names>YC</given-names></name>, <name><surname>Laslo</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities</article-title>. <source>Molecular Cell</source>. <year>2010</year><month>May</month>;<volume>38</volume>(<issue>4</issue>):<fpage>576</fpage>–<lpage>89</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><?supplied-pmid 20513432?><pub-id pub-id-type="pmid">20513432</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Schreiber</surname><given-names>J</given-names></name>, <name><surname>Singh</surname><given-names>R</given-names></name>, <name><surname>Bilmes</surname><given-names>J</given-names></name>, <name><surname>Noble</surname><given-names>WS</given-names></name>. <article-title>A pitfall for machine learning methods aiming to predict across cell types</article-title>. <source>Genome Biol</source>. <year>2020</year><month>Dec</month>;<volume>21</volume>(<issue>1</issue>):<fpage>282</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13059-020-02177-y</pub-id><?supplied-pmid 33213499?><pub-id pub-id-type="pmid">33213499</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Sloan</surname><given-names>CA</given-names></name>, <name><surname>Chan</surname><given-names>ET</given-names></name>, <name><surname>Davidson</surname><given-names>JM</given-names></name>, <name><surname>Malladi</surname><given-names>VS</given-names></name>, <name><surname>Strattan</surname><given-names>JS</given-names></name>, <name><surname>Hitz</surname><given-names>BC</given-names></name>, <etal>et al</etal>. <article-title>ENCODE data at the ENCODE portal</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year><month>Jan</month><day>4</day>;<volume>44</volume>(<issue>D1</issue>):<fpage>D726</fpage>–<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkv1160</pub-id><?supplied-pmid 26527727?><pub-id pub-id-type="pmid">26527727</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref036">
      <label>36</label>
      <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>CA</given-names></name>, <name><surname>Hitz</surname><given-names>BC</given-names></name>, <name><surname>Sloan</surname><given-names>CA</given-names></name>, <name><surname>Chan</surname><given-names>ET</given-names></name>, <name><surname>Davidson</surname><given-names>JM</given-names></name>, <name><surname>Gabdank</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>The Encyclopedia of DNA elements (ENCODE): data portal update</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year><day>04</day>;<volume>46</volume>(<issue>D1</issue>):<fpage>D794</fpage>–<lpage>801</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkx1081</pub-id><?supplied-pmid 29126249?><pub-id pub-id-type="pmid">29126249</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Andersson</surname><given-names>R</given-names></name>, <name><surname>Gebhard</surname><given-names>C</given-names></name>, <name><surname>Miguel-Escalada</surname><given-names>I</given-names></name>, <name><surname>Hoof</surname><given-names>I</given-names></name>, <name><surname>Bornholdt</surname><given-names>J</given-names></name>, <name><surname>Boyd</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>An atlas of active enhancers across human cell types and tissues</article-title>. <source>Nature</source>. <year>2014</year><month>Mar</month><day>27</day>;<volume>507</volume>(<issue>7493</issue>):<fpage>455</fpage>–<lpage>61</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature12787</pub-id><?supplied-pmid 24670763?><pub-id pub-id-type="pmid">24670763</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref038">
      <label>38</label>
      <mixed-citation publication-type="journal"><name><surname>Lizio</surname><given-names>M</given-names></name>, <name><surname>Harshbarger</surname><given-names>J</given-names></name>, <name><surname>Shimoji</surname><given-names>H</given-names></name>, <name><surname>Severin</surname><given-names>J</given-names></name>, <name><surname>Kasukawa</surname><given-names>T</given-names></name>, <name><surname>Sahin</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Gateways to the FANTOM5 promoter level mammalian expression atlas</article-title>. <source>Genome Biol</source>. <year>2015</year><month>Jan</month><day>5</day>;<volume>16</volume>:<fpage>22</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13059-014-0560-6</pub-id><?supplied-pmid 25723102?><pub-id pub-id-type="pmid">25723102</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>Tewhey</surname><given-names>R</given-names></name>, <name><surname>Kotliar</surname><given-names>D</given-names></name>, <name><surname>Park</surname><given-names>DS</given-names></name>, <name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Winnicki</surname><given-names>S</given-names></name>, <name><surname>Reilly</surname><given-names>SK</given-names></name>, <etal>et al</etal>. <article-title>Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay</article-title>. <source>Cell</source>. <year>2016</year><month>Jun</month>;<volume>165</volume>(<issue>6</issue>):<fpage>1519</fpage>–<lpage>29</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.027</pub-id><?supplied-pmid 27259153?><pub-id pub-id-type="pmid">27259153</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Muerdter</surname><given-names>F</given-names></name>, <name><surname>Boryń</surname><given-names>ŁM</given-names></name>, <name><surname>Woodfin</surname><given-names>AR</given-names></name>, <name><surname>Neumayr</surname><given-names>C</given-names></name>, <name><surname>Rath</surname><given-names>M</given-names></name>, <name><surname>Zabidi</surname><given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Resolving systematic errors in widely used enhancer activity assays in human cells</article-title>. <source>Nat Methods.</source><year>2018</year><month>Feb</month>;<volume>15</volume>(<issue>2</issue>):<fpage>141</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.4534</pub-id><?supplied-pmid 29256496?><pub-id pub-id-type="pmid">29256496</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>GD</given-names></name>, <name><surname>Barrera</surname><given-names>A</given-names></name>, <name><surname>McDowell</surname><given-names>IC</given-names></name>, <name><surname>D’Ippolito</surname><given-names>AM</given-names></name>, <name><surname>Majoros</surname><given-names>WH</given-names></name>, <name><surname>Vockley</surname><given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>Human genome-wide measurement of drug-responsive regulatory activity</article-title>. <source>Nat Commun</source>. <year>2018</year><month>Dec</month>;<volume>9</volume>(<issue>1</issue>):<fpage>5317</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-018-07607-x</pub-id><?supplied-pmid 30575722?><pub-id pub-id-type="pmid">30575722</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Khetan</surname><given-names>S</given-names></name>, <name><surname>Kales</surname><given-names>S</given-names></name>, <name><surname>Kursawe</surname><given-names>R</given-names></name>, <name><surname>Jillette</surname><given-names>A</given-names></name>, <name><surname>Ulirsch</surname><given-names>JC</given-names></name>, <name><surname>Reilly</surname><given-names>SK</given-names></name>, <etal>et al</etal>. <article-title>Functional characterization of T2D-associated SNP effects on baseline and ER stress-responsive β cell transcriptional activation</article-title>. <source>Nat Commun</source>. <year>2021</year><month>Dec</month>;<volume>12</volume>(<issue>1</issue>):<fpage>5242</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-021-25514-6</pub-id><?supplied-pmid 34475398?><pub-id pub-id-type="pmid">34475398</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Qian</surname><given-names>F</given-names></name>, <name><surname>Bai</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Ai</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>SEdb: a comprehensive human super-enhancer database</article-title>. <source>Nucleic Acids Research</source>. <year>2019</year><month>Jan</month><day>8</day>;<volume>47</volume>(<issue>D1</issue>):<fpage>D235</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gky1025</pub-id><?supplied-pmid 30371817?><pub-id pub-id-type="pmid">30371817</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>EM</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>W</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Mohlke</surname><given-names>KL</given-names></name>, <name><surname>Chen</surname><given-names>YE</given-names></name>, <etal>et al</etal>. <article-title>GREGOR: evaluating global enrichment of trait-associated variants in epigenomic features using a systematic, data-driven approach</article-title>. <source>Bioinformatics</source>. <year>2015</year><month>Aug</month><day>15</day>;<volume>31</volume>(<issue>16</issue>):<fpage>2601</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btv201</pub-id><?supplied-pmid 25886982?><pub-id pub-id-type="pmid">25886982</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>OTM</given-names></name>, <name><surname>Madaio</surname><given-names>MR</given-names></name>, <name><surname>Shlomchik</surname><given-names>MJ</given-names></name>, <name><surname>Chan</surname><given-names>OIM</given-names></name>, <name><surname>Madaio</surname><given-names>MP</given-names></name>, <name><surname>Shlomchik</surname><given-names>MJ</given-names></name>. <article-title>The central and multiple roles of B cells in lupus pathogenesis</article-title>. <source>Immunol Rev</source>. <year>1999</year><month>Jun</month>;<volume>169</volume>(<issue>1</issue>):<fpage>107</fpage>–<lpage>21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1600-065x.1999.tb01310.x</pub-id><?supplied-pmid 10450512?><pub-id pub-id-type="pmid">10450512</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Ernst</surname><given-names>J</given-names></name>, <name><surname>Kheradpour</surname><given-names>P</given-names></name>, <name><surname>Mikkelsen</surname><given-names>TS</given-names></name>, <name><surname>Shoresh</surname><given-names>N</given-names></name>, <name><surname>Ward</surname><given-names>LD</given-names></name>, <name><surname>Epstein</surname><given-names>CB</given-names></name>, <etal>et al</etal>. <article-title>Mapping and analysis of chromatin state dynamics in nine human cell types</article-title>. <source>Nature</source>. <year>2011</year><month>May</month><day>5</day>;<volume>473</volume>(<issue>7345</issue>):<fpage>43</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature09906</pub-id><?supplied-pmid 21441907?><pub-id pub-id-type="pmid">21441907</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref047">
      <label>47</label>
      <mixed-citation publication-type="other">Chollet F, Others. Keras [Internet]. 2015. Available from: <ext-link xlink:href="https://keras.io" ext-link-type="uri">https://keras.io</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref048">
      <label>48</label>
      <mixed-citation publication-type="other">Abadi M, Agarwal A, Barham P, Brevdo E, Chen Z, Citro C, et al. TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems [Internet]. arXiv; 2016. Available from: <ext-link xlink:href="https://arxiv.org/abs/1603.04467" ext-link-type="uri">https://arxiv.org/abs/1603.04467</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref049">
      <label>49</label>
      <mixed-citation publication-type="other">Kingma DP, Ba J. Adam: A Method for Stochastic Optimization [Internet]. arXiv; 2017. Available from: <ext-link xlink:href="https://arxiv.org/abs/1412.6980" ext-link-type="uri">https://arxiv.org/abs/1412.6980</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Savitzky</surname><given-names>Abraham</given-names></name>, <name><surname>Golay</surname><given-names>MJE</given-names></name>. <article-title>Smoothing and Differentiation of Data by Simplified Least Squares Procedures</article-title>. <source>Anal Chem</source>. <year>1964</year><month>Jul</month><day>1</day>;<volume>36</volume>(<issue>8</issue>):<fpage>1627</fpage>–<lpage>39</lpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref051">
      <label>51</label>
      <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Meyer</surname><given-names>CA</given-names></name>, <name><surname>Eeckhoute</surname><given-names>J</given-names></name>, <name><surname>Johnson</surname><given-names>DS</given-names></name>, <name><surname>Bernstein</surname><given-names>BE</given-names></name>, <etal>et al</etal>. <article-title>Model-based Analysis of ChIP-Seq (MACS).</article-title><source>Genome Biol</source>. <year>2008</year>;<volume>9</volume>(<issue>9</issue>):<fpage>R137</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><?supplied-pmid 18798982?><pub-id pub-id-type="pmid">18798982</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Bolger</surname><given-names>AM</given-names></name>, <name><surname>Lohse</surname><given-names>M</given-names></name>, <name><surname>Usadel</surname><given-names>B</given-names></name>. <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>. <year>2014</year><month>Aug</month><day>1</day>;<volume>30</volume>(<issue>15</issue>):<fpage>2114</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><?supplied-pmid 24695404?><pub-id pub-id-type="pmid">24695404</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref053">
      <label>53</label>
      <mixed-citation publication-type="other">Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM [Internet]. arXiv; 2013. Available from: <ext-link xlink:href="https://arxiv.org/abs/1303.3997" ext-link-type="uri">https://arxiv.org/abs/1303.3997</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref054">
      <label>54</label>
      <mixed-citation publication-type="other">Picard Toolkit [Internet]. Broad Institute; Available from: <ext-link xlink:href="http://broadinstitute.github.io/picard/" ext-link-type="uri">http://broadinstitute.github.io/picard/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>Cao</surname><given-names>J</given-names></name>, <name><surname>Cusanovich</surname><given-names>DA</given-names></name>, <name><surname>Ramani</surname><given-names>V</given-names></name>, <name><surname>Aghamirzaie</surname><given-names>D</given-names></name>, <name><surname>Pliner</surname><given-names>HA</given-names></name>, <name><surname>Hill</surname><given-names>AJ</given-names></name>, <etal>et al</etal>. <article-title>Joint profiling of chromatin accessibility and gene expression in thousands of single cells</article-title>. <source>Science</source>. <year>2018</year><month>Sep</month><day>28</day>;<volume>361</volume>(<issue>6409</issue>):<fpage>1380</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.aau0730</pub-id><?supplied-pmid 30166440?><pub-id pub-id-type="pmid">30166440</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref056">
      <label>56</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR888GEN [Internet]. Stanford University; 2016 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR888GEN/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR888GEN/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref057">
      <label>57</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR525XSO [Internet]. Stanford University; 2019 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR525XSO/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR525XSO/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref058">
      <label>58</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR025UEI [Internet]. Stanford University; 2020 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR025UEI/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR025UEI/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref059">
      <label>59</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR493GDU [Internet]. Stanford University; 2020 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR493GDU/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR493GDU/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref060">
      <label>60</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR002JUR [Internet]. Stanford University; 2018 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR002JUR/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR002JUR/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref061">
      <label>61</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR949WGV [Internet]. Stanford University; 2018 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR949WGV/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR949WGV/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref062">
      <label>62</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR228KEB [Internet]. Stanford University; 2017 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR228KEB/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR228KEB/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref063">
      <label>63</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR646GBV [Internet]. Stanford University; 2020 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR646GBV/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR646GBV/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref064">
      <label>64</label>
      <mixed-citation publication-type="other">ENCODE Consortium. ENCSR654ORD [Internet]. Stanford University; 2018 [cited 2021 Aug 18]. Available from: <ext-link xlink:href="https://www.encodeproject.org/reference-epigenomes/ENCSR654ORD/" ext-link-type="uri">https://www.encodeproject.org/reference-epigenomes/ENCSR654ORD/</ext-link></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref065">
      <label>65</label>
      <mixed-citation publication-type="journal"><name><surname>Bernstein</surname><given-names>BE</given-names></name>, <name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name>, <name><surname>Costello</surname><given-names>JF</given-names></name>, <name><surname>Ren</surname><given-names>B</given-names></name>, <name><surname>Milosavljevic</surname><given-names>A</given-names></name>, <name><surname>Meissner</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The NIH Roadmap Epigenomics Mapping Consortium</article-title>. <source>Nat Biotechnol</source>. <year>2010</year><month>Oct</month>;<volume>28</volume>(<issue>10</issue>):<fpage>1045</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nbt1010-1045</pub-id><?supplied-pmid 20944595?><pub-id pub-id-type="pmid">20944595</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref066">
      <label>66</label>
      <mixed-citation publication-type="journal"><name><surname>Cuddapah</surname><given-names>S</given-names></name>, <name><surname>Jothi</surname><given-names>R</given-names></name>, <name><surname>Schones</surname><given-names>DE</given-names></name>, <name><surname>Roh</surname><given-names>T-Y</given-names></name>, <name><surname>Cui</surname><given-names>K</given-names></name>, <name><surname>Zhao</surname><given-names>K</given-names></name>. <article-title>Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains</article-title>. <source>Genome Research</source>. <year>2008</year><month>Oct</month><day>29</day>;<volume>19</volume>(<issue>1</issue>):<fpage>24</fpage>–<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.082800.108</pub-id><?supplied-pmid 19056695?><pub-id pub-id-type="pmid">19056695</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref067">
      <label>67</label>
      <mixed-citation publication-type="journal"><name><surname>Stitzel</surname><given-names>ML</given-names></name>, <name><surname>Sethupathy</surname><given-names>P</given-names></name>, <name><surname>Pearson</surname><given-names>DS</given-names></name>, <name><surname>Chines</surname><given-names>PS</given-names></name>, <name><surname>Song</surname><given-names>L</given-names></name>, <name><surname>Erdos</surname><given-names>MR</given-names></name>, <etal>et al</etal>. <article-title>Global Epigenomic Analysis of Primary Human Pancreatic Islets Provides Insights into Type 2 Diabetes Susceptibility Loci</article-title>. <source>Cell Metabolism</source>. <year>2010</year><month>Nov</month>;<volume>12</volume>(<issue>5</issue>):<fpage>443</fpage>–<lpage>55</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cmet.2010.09.012</pub-id><?supplied-pmid 21035756?><pub-id pub-id-type="pmid">21035756</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref068">
      <label>68</label>
      <mixed-citation publication-type="journal"><name><surname>Barrett</surname><given-names>T</given-names></name>, <name><surname>Wilhite</surname><given-names>SE</given-names></name>, <name><surname>Ledoux</surname><given-names>P</given-names></name>, <name><surname>Evangelista</surname><given-names>C</given-names></name>, <name><surname>Kim</surname><given-names>IF</given-names></name>, <name><surname>Tomashevsky</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>NCBI GEO: archive for functional genomics data sets—update</article-title>. <source>Nucleic Acids Research</source>. <year>2012</year><month>Nov</month><day>26</day>;<volume>41</volume>(<issue>D1</issue>):<fpage>D991</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">23193258</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref069">
      <label>69</label>
      <mixed-citation publication-type="journal"><name><surname>Edgar</surname><given-names>R.</given-names></name><article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Research</source>. <year>2002</year><month>Jan</month><day>1</day>;<volume>30</volume>(<issue>1</issue>):<fpage>207</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id><?supplied-pmid 11752295?><pub-id pub-id-type="pmid">11752295</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref070">
      <label>70</label>
      <mixed-citation publication-type="journal"><name><surname>Butler</surname><given-names>A</given-names></name>, <name><surname>Hoffman</surname><given-names>P</given-names></name>, <name><surname>Smibert</surname><given-names>P</given-names></name>, <name><surname>Papalexi</surname><given-names>E</given-names></name>, <name><surname>Satija</surname><given-names>R</given-names></name>. <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>. <source>Nat Biotechnol</source>. <year>2018</year><month>May</month>;<volume>36</volume>(<issue>5</issue>):<fpage>411</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><?supplied-pmid 29608179?><pub-id pub-id-type="pmid">29608179</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref071">
      <label>71</label>
      <mixed-citation publication-type="journal"><name><surname>Stuart</surname><given-names>T</given-names></name>, <name><surname>Butler</surname><given-names>A</given-names></name>, <name><surname>Hoffman</surname><given-names>P</given-names></name>, <name><surname>Hafemeister</surname><given-names>C</given-names></name>, <name><surname>Papalexi</surname><given-names>E</given-names></name>, <name><surname>Mauck</surname><given-names>WM</given-names></name>, <etal>et al</etal>. <article-title>Comprehensive Integration of Single-Cell Data</article-title>. <source>Cell</source>. <year>2019</year><month>Jun</month>;<volume>177</volume>(<issue>7</issue>):<fpage>1888</fpage>–<lpage>1902.e21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><?supplied-pmid 31178118?><pub-id pub-id-type="pmid">31178118</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref072">
      <label>72</label>
      <mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>AM</given-names></name>, <name><surname>Liu</surname><given-names>CL</given-names></name>, <name><surname>Green</surname><given-names>MR</given-names></name>, <name><surname>Gentles</surname><given-names>AJ</given-names></name>, <name><surname>Feng</surname><given-names>W</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>. <source>Nat Methods</source>. <year>2015</year><month>May</month>;<volume>12</volume>(<issue>5</issue>):<fpage>453</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id><?supplied-pmid 25822800?><pub-id pub-id-type="pmid">25822800</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009670.ref073">
      <label>73</label>
      <mixed-citation publication-type="journal"><name><surname>Buniello</surname><given-names>A</given-names></name>, <name><surname>MacArthur</surname><given-names>JAL</given-names></name>, <name><surname>Cerezo</surname><given-names>M</given-names></name>, <name><surname>Harris</surname><given-names>LW</given-names></name>, <name><surname>Hayhurst</surname><given-names>J</given-names></name>, <name><surname>Malangone</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</article-title>. <source>Nucleic Acids Research</source>. <year>2019</year><month>Jan</month><day>8</day>;<volume>47</volume>(<issue>D1</issue>):<fpage>D1005</fpage>–<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id><?supplied-pmid 30445434?><pub-id pub-id-type="pmid">30445434</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
